{"study_id": 52485, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to determine whether combining mucosal protection (Esoxx, containing hyaluronic acid-chondroitin sulphate) with acid suppression (PPIs) improves symptom relief in NERD patients compared to PPI treatment alone.", "results_summary": "Esoxx combined with PPI therapy significantly improved symptom relief (52.6% vs. 32.1% with placebo) and health-related quality of life in NERD patients, demonstrating a synergistic effect.", "population_specificity": "154 patients with non-erosive reflux disease (NERD).", "effective_dosage": "Not specified (standard dose PPIs + Esoxx formulation).", "study_duration": "2 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:02.311605+00:00"}
{"study_id": 52487, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the role of chondroitin sulfate-degrading enzymes (CS lyases) in neural development, their structure, function, and applications.", "results_summary": "The study highlights that CS lyases can modify chondroitin sulfate chains, influencing signaling pathways and producing oligosaccharides with immune-modulatory, anti-inflammatory, and neuroprotective properties. It also discusses their biotechnological and therapeutic applications.", "population_specificity": "Not specified (review of existing research)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:02.574395+00:00"}
{"study_id": 52484, "supplement_id": 1021, "safety_score": "80", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to compare the effectiveness and tolerability of intravesical chondroitin sulphate (CS) 2% versus dimethyl sulphoxide (DMSO) 50% in treating painful bladder syndrome/interstitial cystitis (PBS/IC).", "results_summary": "CS 2% showed significantly better efficacy than DMSO 50%, with 72.7% of CS-treated patients reporting moderate or marked improvement compared to 14% in the DMSO group. CS also demonstrated superior pain reduction, nocturia improvement, and tolerability, while DMSO had a high dropout rate due to adverse effects.", "population_specificity": "Patients with painful bladder syndrome/interstitial cystitis (PBS/IC).", "effective_dosage": "2% CS, administered as 6 weekly instillations.", "study_duration": "6 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:03.659659+00:00"}
{"study_id": 52486, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether combining pulsed Nd:YAG laser therapy with glucosamine/chondroitin sulfate (GCS) and exercises improved pain, knee function, synovial thickness, and femoral cartilage thickness in knee osteoarthritis patients compared to GCS plus exercises or exercises alone.", "results_summary": "The study found that GCS combined with exercises (GCS + EX) significantly reduced pain and functional disability (VAS and WOMAC scores) after 6 weeks, with sustained effects at 3 months. However, the combination of pulsed Nd:YAG laser, GCS, and exercises (HILT + GCS + EX) showed superior reductions in synovial thickness compared to GCS + EX or placebo laser + exercises, though femoral cartilage thickness changes were nonsignificant across all groups.", "population_specificity": "67 male patients with knee osteoarthritis (mean age 53.85 years, mean BMI 28.56).", "effective_dosage": "Not specified in the abstract.", "study_duration": "6 weeks of treatment, with follow-up at 3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:05.364193+00:00"}
{"study_id": 52493, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to investigate the effects of chondroitin sulfate on serum Coll2-1 levels and its impact on pain and function in patients with knee osteoarthritis.", "results_summary": "Chondroitin sulfate significantly reduced Coll2-1 serum levels in responders at 3 and 6 months, decreased pain, and improved function. The study also introduced a new method to categorize metabolic responders based on individual biomarker variations.", "population_specificity": "72 patients with unilateral symptomatic knee osteoarthritis.", "effective_dosage": "800 mg/day", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:09.676559+00:00"}
{"study_id": 52492, "supplement_id": 1021, "safety_score": "85", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to compare the effects of chondroitin sulfate (CS) versus celecoxib on cartilage volume loss (CVL) in knee osteoarthritis (OA) patients using quantitative MRI over 24 months.", "results_summary": "CS significantly reduced CVL in the medial compartment and medial condyle compared to celecoxib at 24 months, with a trend toward reduced synovial thickness. Both treatments showed similar safety profiles and symptom reduction.", "population_specificity": "Knee osteoarthritis patients (n=138 in mITT, n=120 in ATP).", "effective_dosage": "CS 1200 mg/day, celecoxib 200 mg/day.", "study_duration": "24 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:10.076858+00:00"}
{"study_id": 52494, "supplement_id": 1021, "safety_score": "85", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to compare the efficacy, safety, and cost-effectiveness of intravesical HA/CS versus DMSO in women with bladder pain syndrome/interstitial cystitis (BPS/IC).", "results_summary": "HA/CS showed a greater reduction in pain intensity at 6 months compared to DMSO, with fewer treatment-related adverse events. Both treatments improved quality of life, but HA/CS had a more favorable cost-effectiveness profile.", "population_specificity": "110 women with BPS/IC.", "effective_dosage": "1.6% HA plus 2.0% CS, administered weekly.", "study_duration": "13 weeks (with follow-up at 3 and 6 months).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:11.273945+00:00"}
{"study_id": 52496, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the efficacy of intravesical HA/chondroitin sulfate (CS) instillation in improving symptoms of interstitial cystitis/painful bladder syndrome.", "results_summary": "The study found significant improvements in pain symptoms (VAS), quality of life (ICSI, ICPI), and other outcomes like frequency and nocturia with HA/CS instillation. The results were consistent across fixed-effect and random-effect models.", "population_specificity": "Patients with interstitial cystitis/painful bladder syndrome (390 participants across 10 studies).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:11.477083+00:00"}
{"study_id": 52491, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to determine if oral chondroitin sulfate (combined with hyaluronic acid, curcumin, and quercetin) could prevent recurrent cystitis in postmenopausal women, and whether its efficacy was enhanced by concurrent vaginal estrogen therapy.", "results_summary": "The combination therapy showed significant efficacy in reducing recurrent urinary tract infections, particularly when used alongside vaginal estrogen therapy, with symptom improvement observed in all groups by the 12-month follow-up.", "population_specificity": "Postmenopausal women with mild-to-moderate urogenital atrophy and a history of recurrent urinary tract infections.", "effective_dosage": "Not specified", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:11.711531+00:00"}
{"study_id": 52497, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to assess the efficacy and safety of intravesical instillation treatments, including chondroitin sulfate (CS), for interstitial cystitis/painful bladder syndrome (IC/PBS) patients.", "results_summary": "The study did not highlight specific efficacy results for chondroitin sulfate (CS) compared to other treatments like BoNTA, BCG, or PPS, which showed more significant improvements in symptoms. CS was included in the network meta-analysis but did not stand out as a top-performing treatment.", "population_specificity": "Patients with interstitial cystitis/painful bladder syndrome (IC/PBS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:13.036739+00:00"}
{"study_id": 52495, "supplement_id": 1021, "safety_score": "90", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to evaluate the clinical efficacy of a preservative-free fixed combination of xanthan gum and chondroitin sulfate in treating dry eye disease compared to a polyethylene glycol/propylene glycol solution.", "results_summary": "The study found that xanthan gum/chondroitin sulfate showed similar clinical efficacy to polyethylene glycol/propylene glycol, improving Schirmer test results, tear film break-up time, and OSDI scores, with no significant differences between treatments. Adverse events were unrelated to the interventions.", "population_specificity": "148 subjects with dry eye disease.", "effective_dosage": "Chondroitin sulfate 0.1% ophthalmic solution, self-dosed four times daily.", "study_duration": "60 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:13.574635+00:00"}
{"study_id": 52498, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy and safety of chondroitin as a complementary approach for managing chronic pain and related disability in conditions like osteoarthritis and back pain.", "results_summary": "The abstract does not provide specific results for chondroitin, but it is included among natural product supplements examined for managing chronic pain, suggesting it may have some efficacy in pain relief.", "population_specificity": "Individuals with chronic pain conditions such as back pain, fibromyalgia, osteoarthritis, neck pain, and severe headaches or migraines.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:14.936580+00:00"}
{"study_id": 52499, "supplement_id": 1021, "safety_score": "90", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the safety and efficacy of STNM01, a synthetic RNA oligonucleotide targeting CHST15, in reducing mucosal lesions and fibrosis in Crohn's disease patients refractory to conventional therapy.", "results_summary": "STNM01 was well tolerated with no drug-related adverse effects and showed no detectable plasma concentrations. Seven of nine treated subjects exhibited reduced segmental SES-CD scores, and histological analysis confirmed reduced fibrosis.", "population_specificity": "Crohn's disease patients with active mucosal lesions refractory to conventional therapy (n=18).", "effective_dosage": "Single-dose endoscopic submucosal injections at 2.5nM, 25nM, and 250nM concentrations.", "study_duration": "Safety monitored for 30 days; pharmacokinetics for 24 hours.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:19.731684+00:00"}
{"study_id": 52500, "supplement_id": 1021, "safety_score": "85", "efficacy_score": 30, "quality_score": 80, "study_goal": "The researchers aimed to assess the efficacy and safety of chondroitin sulfate (CS) combined with glucosamine sulfate (GS) compared to placebo in reducing joint pain and functional impairment in patients with symptomatic knee osteoarthritis.", "results_summary": "The study found that CS/GS combination therapy was inferior to placebo in reducing joint pain in the modified intent-to-treat population, though both treatments similarly improved WOMAC scores. Severe adverse events were rare and equally distributed between groups.", "population_specificity": "Patients with Kellgren/Lawrence grade 2 or 3 radiographic knee osteoarthritis and moderate-to-severe knee pain.", "effective_dosage": "1,200 mg CS plus 1,500 mg GS, single oral daily dose.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:20.160319+00:00"}
{"study_id": 52504, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of a combined self-management and exercise program (PLE(2)NO) alongside chondroitin and glucosamine supplementation on knee osteoarthritis symptoms and related outcomes.", "results_summary": "The abstract describes the study protocol but does not report specific results regarding chondroitin's effects, as it is a pre-intervention description.", "population_specificity": "Elderly patients (aged above 60 years) with clinical and radiographic knee osteoarthritis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:21.531889+00:00"}
{"study_id": 52502, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of chondroitin sulfate in heparin-induced thrombocytopenia (HIT), particularly how HIT antibodies recognize PF4 bound to chondroitin sulfate.", "results_summary": "The study found that HIT antibodies can recognize PF4 bound to chondroitin sulfate, explaining cases of HIT without recent heparin exposure (e.g., delayed-onset HIT or spontaneous HIT syndrome). This suggests a potential mechanism for HIT independent of heparin.", "population_specificity": "Patients with heparin-induced thrombocytopenia (HIT) or related prothrombotic disorders.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:21.658796+00:00"}
{"study_id": 52503, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the clinical presentations and potential disease mechanisms of aggrecanopathies caused by mutations in the ACAN gene.", "results_summary": "The abstract discusses the phenotypic spectrum of skeletal dysplasias linked to ACAN mutations but does not provide specific findings on Chondroitin's effects. It highlights the lack of understanding of disease pathways underlying aggrecanopathies.", "population_specificity": "Human and animal models with aggrecanopathies (e.g., spondyloepimetaphyseal dysplasia, spondyloepiphyseal dysplasia, familial osteochondritis dissecans, short stature syndromes).", "effective_dosage": "Not available", "study_duration": "Not applicable (review study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:22.006914+00:00"}
{"study_id": 52505, "supplement_id": 1021, "safety_score": "90", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to review the clinical benefits, safety, and applications of Chondroitin sulfate (CS) in osteoarthritis (OA) treatment and tissue engineering.", "results_summary": "CS demonstrated anti-inflammatory activity, pain reduction, and structural benefits in OA-affected joints, with no significant side effects reported in clinical trials. It also showed potential in tissue regeneration when combined with other biopolymers.", "population_specificity": "Patients with symptomatic osteoarthritis (finger, knee, hip, low back, facial joints) and researchers in tissue engineering.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:22.862314+00:00"}
{"study_id": 52501, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to compare the expression of CAF-related proteins, including chondroitin sulfate proteoglycan (NG2), in invasive lobular carcinoma (ILC) versus invasive carcinoma of no special type (NST) and assess their clinical implications.", "results_summary": "The study found that stromal cells in invasive carcinoma (NST) expressed high levels of NG2 (chondroitin sulfate proteoglycan), while ILC stromal cells showed higher expression of other CAF-related proteins. NG2 expression was not directly linked to clinical outcomes in this study.", "population_specificity": "Patients with invasive lobular carcinoma (ILC, n=104) and invasive carcinoma of no special type (NST, n=524).", "effective_dosage": "Not available", "study_duration": "Not applicable (observational study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:24.437370+00:00"}
{"study_id": 52506, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the shared properties of neural stem cells (NSCs) and cancer stem cells (CSCs), focusing on the role of extracellular matrix molecules like chondroitin sulfate proteoglycans in glioblastoma multiforme (GBM).", "results_summary": "The abstract highlights that chondroitin sulfate proteoglycans, such as DSD-1-PG/phosphacan, influence the behavior of NSCs/CSCs and brain tumor progression, particularly in GBM. It suggests these molecules may play a role in tumor heterogeneity and stem cell maintenance.", "population_specificity": "The study focuses on glioblastoma multiforme (GBM) and its associated cancer stem cells, not human consumption or clinical populations.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:27.683075+00:00"}
{"study_id": 52507, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers discussed the role of chondroitin sulfate proteoglycans in forming inhibitory glial scars post-spinal cord injury and explored potential neuroregenerative strategies, including glial scar degradation.", "results_summary": "The abstract mentions that chondroitin sulfate proteoglycans contribute to the formation of an inhibitory glial scar, which impedes long-term regeneration after spinal cord injury. Potential strategies like glial scar degradation were highlighted as key neuroregenerative approaches for future research.", "population_specificity": "Patients with spinal cord injuries.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:28.723921+00:00"}
{"study_id": 52510, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of chondroitin sulfate as an intravesical treatment for bladder pain syndrome/interstitial cystitis (BPS/IC).", "results_summary": "The abstract mentions chondroitin sulfate as one of the conventional drugs analyzed for treating BPS/IC, but specific results regarding its efficacy are not detailed. It is grouped with other treatments showing potential for symptom improvement.", "population_specificity": "Patients with bladder pain syndrome/interstitial cystitis (BPS/IC).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:30.021785+00:00"}
{"study_id": 52508, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to compare the clinical effectiveness of intravesical administration of combined hyaluronic acid and chondroitin sulfate (HA+CS) versus standard management in reducing recurrent urinary tract infections (RUTIs) in adult women.", "results_summary": "The study found that HA+CS reduced the risk of bacteriologically confirmed recurrences compared to standard management, particularly with \u22655 instillations, but showed no significant difference in total recurrence rates or time to first recurrence. The effectiveness of HA+CS improved over time, unlike antibiotic prophylaxis.", "population_specificity": "276 adult women with recurrent urinary tract infections from 7 European centers.", "effective_dosage": "Not specified (intravesical administration, frequency implied by \u22655 instillations).", "study_duration": "Follow-up period of 12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:30.521838+00:00"}
{"study_id": 52509, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to clarify the role of chondroitin sulfate, alone or in combination with glucosamine, as a potential disease-modifying osteoarthritis drug (DMOAD) by reviewing its effects on pain, function, and disease progression.", "results_summary": "The study found that chondroitin sulfate and glucosamine showed beneficial effects on pain, function, and disease progression in osteoarthritis, though efficacy results from randomized trials were inconsistent. Meta-analyses supported their structure-modifying capacity, but absolute certainty on disease modification remains unclear.", "population_specificity": "Patients affected by osteoarthritis (specific demographics not detailed in the abstract).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:31.289953+00:00"}
{"study_id": 52511, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess the efficacy and safety of CartiJoint Forte (containing chondroitin sulfate) combined with physical therapy in treating knee osteoarthritis.", "results_summary": "The study found that CartiJoint Forte, when added to physical therapy, reduced pain at motion and improved algofunctional scores (Lequesne Index) in knee OA patients, though no significant changes were observed in knee ROM or inflammation markers.", "population_specificity": "Outpatients with knee osteoarthritis referred to the Rehabilitation Departments of two University Hospitals (N=53, with 26 in the experimental group).", "effective_dosage": "Two tablets of CartiJoint Forte daily (specific chondroitin sulfate dosage not detailed).", "study_duration": "8 weeks of intervention, with follow-up at 12 weeks.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:31.919526+00:00"}
{"study_id": 52512, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine if urinary indices of GAG fragmentation, including chondroitin sulfate, are associated with outcomes like acute kidney injury and mortality in critically ill patients with septic shock or ARDS.", "results_summary": "The study found that early indices of GAG fragmentation, including chondroitin sulfate, correlated with renal dysfunction and hospital mortality in septic shock and ARDS patients, with predictive validity confirmed via an inexpensive assay.", "population_specificity": "Critically ill patients (30 with septic shock, 25 trauma ICU controls, 70 ARDS patients).", "effective_dosage": "Not specified", "study_duration": "Urine samples collected within 24 hours of ICU admission (septic shock/trauma) or serially (ARDS).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:32.771435+00:00"}
{"study_id": 52513, "supplement_id": 1021, "safety_score": "85", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the role of chondroitin sulfate as part of background maintenance therapy for knee osteoarthritis, focusing on its safety, efficacy, and disease-modifying effects.", "results_summary": "The study found that chondroitin sulfate, as a symptomatic slow-acting drug for osteoarthritis (SYSADOA), demonstrated high-quality evidence for efficacy in managing OA pain and function, with potential disease-modifying effects and long-term benefits like delaying joint replacement. It was recommended as part of step 1 therapy due to its favorable safety profile.", "population_specificity": "Patients with knee osteoarthritis in primary care clinical practice.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:33.764721+00:00"}
{"study_id": 52514, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the efficacy and clinical benefits of prescription patented crystalline glucosamine sulfate (pCGS) and chondroitin sulfate (CS) in managing knee osteoarthritis, including symptom control and disease progression.", "results_summary": "The study found that pCGS (1500mg once daily) demonstrated superiority over other glucosamine formulations, delayed joint structural changes, reduced the need for additional pain medications and NSAIDs, and decreased long-term healthcare costs. Treatment for at least 12 months also reduced the need for total joint replacement for up to 5 years post-treatment.", "population_specificity": "Patients with knee osteoarthritis.", "effective_dosage": "1500mg once daily (pCGS).", "study_duration": "At least 12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:37.470727+00:00"}
{"study_id": 52517, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to describe the biosynthesis pathways of glycosaminoglycans (GAGs), including chondroitin sulfate, and their role in connective tissue disorders.", "results_summary": "The abstract outlines the structure and biosynthesis of GAGs, including chondroitin sulfate, and discusses their association with connective tissue disorders, but does not report specific findings on chondroitin's effects.", "population_specificity": "Patients with inborn errors of GAG biosynthesis and connective tissue disorders.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:38.890297+00:00"}
{"study_id": 52515, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess the specificity and enzymatic activity of rHyal_Sk against chondroitin sulfates compared to other hyaluronidases (BTH and PH20).", "results_summary": "The study found that rHyal_Sk demonstrated high substrate specificity for hyaluronic acid (HA) and no inhibition from GAGs sulfate, but its direct effects on chondroitin were not detailed beyond initial specificity assessment.", "population_specificity": "In vitro and in vivo (nude mice) models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:41.006473+00:00"}
{"study_id": 52516, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review clinical studies on osteoarthritis treatments, including Chondroitin sulfate, to assess its symptom and structural outcomes.", "results_summary": "The study reported symptom outcomes for Chondroitin sulfate among pharmacologic treatments for osteoarthritis, indicating its inclusion in clinical research, but specific efficacy details were not highlighted. Structural outcomes were also noted for Chondroitin sulfate, suggesting potential benefits in osteoarthritis management.", "population_specificity": "Adults aged 19+ with osteoarthritis.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:41.653329+00:00"}
{"study_id": 52518, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of ADAMTS5 in aggrecan degradation in osteoarthritis and evaluate monoclonal antibodies as potential inhibitors of ADAMTS5 for arthritis therapy.", "results_summary": "The study identified ADAMTS5 as a key mediator of aggrecan loss in osteoarthritis and characterized high-affinity monoclonal antibodies targeting ADAMTS5, which showed promise as selective aggrecanase inhibitors. The antibodies' epitopes provided new insights into ADAMTS5 interactions with aggrecan, suggesting potential therapeutic applications for arthritis.", "population_specificity": "Not specified (focused on molecular mechanisms and mouse models, with implied relevance to humans).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:41.730192+00:00"}
{"study_id": 52521, "supplement_id": 1021, "safety_score": "85", "efficacy_score": 75, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the effectiveness and safety of chondroitin, alone and in combination with glucosamine, compared to celecoxib and placebo for treating knee osteoarthritis.", "results_summary": "Chondroitin alone showed statistically significant reduction in joint space narrowing, and the combination of glucosamine plus chondroitin demonstrated clinically significant improvement in function and pain relief compared to placebo. No significant differences in major adverse effects were observed among the treatment options.", "population_specificity": "Patients with knee osteoarthritis (16,427 participants across 54 studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:42.547376+00:00"}
{"study_id": 52519, "supplement_id": 1021, "safety_score": "90", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to determine whether a supplement containing chondroitin sulfate, among other ingredients, could improve knee-joint and locomotor functions in subjects with knee pain.", "results_summary": "The study found no significant difference between the supplement and placebo groups overall, but subgroup analyses showed improvements in knee-extensor strength and walking speed for those with mild-to-severe knee pain or K-L grade I. No adverse effects were reported.", "population_specificity": "100 Japanese subjects (average age 51.8\u00b10.8 years) with knee pain.", "effective_dosage": "60 mg of chondroitin sulfate per day, combined with other ingredients.", "study_duration": "16 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:42.778723+00:00"}
{"study_id": 52520, "supplement_id": 1021, "safety_score": "90", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to assess the effectiveness and safety of intra-articular injections of Arthrum HCS\u00ae (a combination of hyaluronic acid and chondroitin sulfate) in treating knee osteoarthritis.", "results_summary": "The study found significant pain reduction (WOMAC subscore A decreased from 52.1 to 20.5 at 6 months) and improved mobility, with high investigator satisfaction. Only one minor adverse effect (knee tumefaction) was reported.", "population_specificity": "Men and women over 40 years with documented knee osteoarthritis and WOMAC subscore A \u226525.", "effective_dosage": "40 mg chondroitin sulfate combined with 40 mg hyaluronic acid in 2 mL, administered as three weekly intra-articular injections.", "study_duration": "3 weeks (injections), with follow-up assessments at 1, 3, and 6 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:44.332035+00:00"}
{"study_id": 52522, "supplement_id": 1021, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the effectiveness of intravesical instillation of hyaluronic acid plus chondroitin sulfate versus antibiotic prophylaxis in preventing recurrent bacterial cystitis.", "results_summary": "The study found that intravesical HA + CS was more effective than antibiotic prophylaxis, with a higher proportion of patients remaining free from UTIs (36.7% vs. 21.0%) and better tolerability.", "population_specificity": "Women affected by recurrent bacterial cystitis.", "effective_dosage": "High concentration of HA + CS in 50 mL water with calcium chloride, administered weekly for the 1st month and then monthly for 4 months.", "study_duration": "5 months (1 month weekly, followed by 4 months monthly).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:47.191232+00:00"}
{"study_id": 52523, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the roles of small leucine-rich repeat proteoglycans (SLRPs), including chondroitin/dermatan sulphate GAGs, in atherosclerosis development and progression.", "results_summary": "The study found that chondroitin/dermatan sulphate GAG side chains are implicated in lipid retention in atherosclerosis and that SLRPs interact with collagens, growth factors, and cytokines, impacting inflammation, immune responses, and wound healing\u2014processes relevant to plaque development.", "population_specificity": "Animal models and atherosclerotic plaque samples (no specific human population mentioned).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:49.166175+00:00"}
{"study_id": 52526, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the roles of proteoglycans, including chondroitin sulfate (CS), in normal central nervous system (CNS) function and pathological conditions.", "results_summary": "The abstract highlights that chondroitin sulfate proteoglycans (CSPGs) play critical roles in CNS development, function, and damage-response, suggesting potential therapeutic applications for neurological conditions.", "population_specificity": "Not specified (review of existing literature on CNS function and pathology).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:49.724468+00:00"}
{"study_id": 52525, "supplement_id": 1021, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the incidence rate of IBD relapse and the effect of chondroitin sulphate on pro-inflammatory protein levels in patients with IBD in remission.", "results_summary": "Chondroitin sulphate treatment was associated with a low IBD relapse rate (3.4% per patient-year), reduced OA-related pain, and increased serum VEGFA levels.", "population_specificity": "Patients with inflammatory bowel disease (IBD) in remission, including 19 with ulcerative colitis and 18 with Crohn's disease.", "effective_dosage": "Not specified", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:49.843270+00:00"}
{"study_id": 52524, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the role of chondroitin sulfate A (CSA) in placental malaria pathogenesis and its potential as a target for vaccine development.", "results_summary": "The study found that P. falciparum parasites bind to CSA to sequester in the placenta, and VAR2CSA, a protein mediating this adhesion, is a leading vaccine target. Approaches to identify effective VAR2CSA fragments for inducing broadly active antibodies are summarized, with two products nearing human clinical trials.", "population_specificity": "Pregnant women (specifically those affected by placental malaria).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:50.516699+00:00"}
{"study_id": 52527, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review GHK's role in skin regeneration and its broader therapeutic potential, including its effects on chondroitin sulfate synthesis.", "results_summary": "GHK stimulates the synthesis of chondroitin sulfate and other extracellular matrix components, accelerates wound healing across multiple tissues, and modulates gene expression to promote healthier cellular states. It also shows cosmetic benefits like improving skin elasticity and reducing wrinkles.", "population_specificity": "Not specified (broadly includes humans, rats, mice, pigs, and dogs based on referenced studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:51.400534+00:00"}
{"study_id": 52528, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to understand the role of reactive oligodendrocyte precursor cells (OPCs), particularly their expression of NG2 chondroitin sulfate proteoglycan, in response to spinal cord injury and their potential therapeutic implications.", "results_summary": "The study found that reactive OPCs rapidly divide and accumulate around injury sites, contributing to glial scar formation and remyelination, but may also produce axon-growth inhibitory proteoglycans and interact with inflammatory cells in complex ways.", "population_specificity": "Spinal cord injury models (not human subjects).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:51.634094+00:00"}
{"study_id": 52529, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine whether acute exacerbations of COPD (AECOPDs) are associated with increased levels of chondroitin sulfate in BAL and its potential role in airway remodeling and lung function decline.", "results_summary": "Chondroitin sulfate levels were significantly increased in BAL during AECOPDs and negatively correlated with FEV1 % predicted, suggesting an association with airway obstruction. It was also correlated with MMPs, indicating potential cleavage from proteoglycans during exacerbations.", "population_specificity": "97 patients with COPD (53 stable, 44 with AECOPD) undergoing diagnostic bronchoscopy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:53.756129+00:00"}
{"study_id": 52530, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the potential of CSPG4 as a target for CAR-T cell therapy in treating solid tumors and inhibiting tumor-associated angiogenesis.", "results_summary": "The study found that CSPG4 is highly expressed in various human malignancies and tumor-associated pericytes, making it a promising target for CAR-T cell therapy. Preclinical data support the clinical translation of CSPG4-specific CAR-T cells for broad-spectrum solid tumor treatment.", "population_specificity": "Cancer patients with solid tumors (preclinical focus).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:56.128999+00:00"}
{"study_id": 52533, "supplement_id": 1021, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the effectiveness of a combined sodium hyaluronate and chondroitin sulfate (HA + CS) injection versus a triamcinolone injection in treating lateral epicondylitis.", "results_summary": "The HA + CS group showed statistically significant improvements in function scores at 3 months and better pain and function scores at 6 months compared to the triamcinolone group, with clinically significant improvements noted.", "population_specificity": "57 patients with clinically diagnosed lateral epicondylitis.", "effective_dosage": "Single injection of HA + CS combination (specific dosage not detailed in abstract).", "study_duration": "6 months (follow-up period).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:21:59.151232+00:00"}
{"study_id": 52534, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to illustrate the application of NMR spectroscopy in determining the structural uniqueness and therapeutic potential of invertebrate-derived glycosaminoglycans (GAGs), including fucosylated chondroitin sulfate.", "results_summary": "The study found that invertebrate-derived GAGs, such as fucosylated chondroitin sulfate, exhibit distinct structural and functional properties compared to mammalian GAGs, suggesting unique therapeutic mechanisms. These GAGs show promise as candidates for treating various diseases.", "population_specificity": "Invertebrate-derived GAGs (e.g., from holothurians, snails, ascidians, gastropods, and shrimp).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:00.137596+00:00"}
{"study_id": 52532, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the impact of chondroitin sulfate (CS) combined with hyaluronic acid (HA) on reducing nocturia in men with post-radiation bladder pain after prostate cancer radiotherapy.", "results_summary": "The study found that bladder instillation therapy with HA and CS significantly reduced nocturnal voiding frequency, with a 24.4% decrease in ICSI-Q3 scores and a 30.5% decrease in ICPI-Q2 scores. The results were statistically significant, suggesting efficacy in alleviating nocturia symptoms.", "population_specificity": "Men with symptomatic cystitis after external radiotherapy for prostate cancer.", "effective_dosage": "Weekly instillation for the first month, then on weeks 6, 8, and 12 (specific dosage not provided).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:00.434008+00:00"}
{"study_id": 52535, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the anti-inflammatory, immunostimulatory, and anti-tumor properties of sea cucumber extracts, including fucosylated chondroitin sulfate.", "results_summary": "The study found that sea cucumber extracts, particularly Frondanol A5, demonstrated efficacy in preventing colon cancer in rodent models and exhibited potential anti-inflammatory and immunostimulatory effects. The extract contains bioactive compounds like fucosylated chondroitin sulfate, which may contribute to these benefits.", "population_specificity": "Rodent models (not specified if human subjects were included).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:00.786156+00:00"}
{"study_id": 52531, "supplement_id": 1021, "safety_score": "100", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the efficacy of short-term intravesical chondroitin sulphate treatment in reducing symptoms of chronic radiotherapy- or chemotherapy-associated cystitis.", "results_summary": "The study found that 80% of patients showed improvement or became symptom-free after six weeks of treatment, with significant reductions in urinary urgency, pollakisuria, urge frequency, and lower abdominal pain. Hematuria resolved completely in all affected patients, and treatment tolerance was rated as 'good' or 'very good' by 93% of participants.", "population_specificity": "Patients with chronic radiotherapy- or chemotherapy-associated cystitis (mean age 68.5 years; 50% male).", "effective_dosage": "0.2% chondroitin sulphate, 40 mL once weekly.", "study_duration": "6 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:00.938700+00:00"}
{"study_id": 52536, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of Chondroitin Sulfate Proteoglycans (CSPGs) in normal and pathological CNS function and review preclinical therapies targeting CSPGs for CNS injury repair.", "results_summary": "CSPGs play critical roles in CNS development and injury response, limiting axonal plasticity and regeneration post-injury. Recent preclinical therapies targeting CSPGs show potential for promoting spinal cord repair and regeneration.", "population_specificity": "Preclinical studies (animal models) and theoretical applications to human CNS injuries.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:01.572371+00:00"}
{"study_id": 52537, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the role of chondroitin sulfate proteoglycans (CSPGs) in CNS recovery and plasticity, particularly focusing on the effects of chondroitinase ABC (ChABC) treatment on axon regeneration, memory retention, and plasticity.", "results_summary": "ChABC treatment after spinal cord injury promoted axon regeneration and increased plasticity, leading to functional restoration when combined with rehabilitation. ChABC also improved object recognition memory in tauopathy models of Alzheimer's disease and demonstrated the critical role of CSPGs in controlling plasticity through PNNs.", "population_specificity": "Animal models (spinal cord injury and tauopathy models of Alzheimer's disease)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:03.956493+00:00"}
{"study_id": 52538, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to analyze the heterogeneity of circulating tumor cells (CTCs) in melanoma patients, focusing on the co-expression of melanoma markers, including melanoma-associated chondroitin sulphate proteoglycan, and tumor-initiating markers.", "results_summary": "The study found that CTCs were highly heterogeneous, with limited co-expression of the analyzed markers. RANK(+) CTCs increased significantly in patients undergoing targeted therapy and were associated with shorter progression-free survival.", "population_specificity": "Late-stage (III-IV) and early-stage (I-II) melanoma patients (N=56).", "effective_dosage": "Not available", "study_duration": "Not applicable (observational study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:04.890926+00:00"}
{"study_id": 52539, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to explore the potential of less-known polysaccharides, including Chondroitin, as nanoparticle matrix materials for protein and peptide delivery.", "results_summary": "The abstract does not provide specific findings about Chondroitin's effects but highlights the general advantages of polysaccharides, such as biodegradability, biocompatibility, and structural flexibility, for nanoparticle applications.", "population_specificity": "Not specified", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:06.609788+00:00"}
{"study_id": 52541, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the role of chondroitinase ABC (chABC) in degrading inhibitory CSPGs to enhance peripheral nerve regeneration after injury.", "results_summary": "The study found that chABC effectively degrades CSPGs, promoting axon regeneration across nerve injury gaps, and shows potential synergism with other therapies like stem cell transplantation. However, limitations such as thermal instability and short physiologic longevity hinder its clinical adoption.", "population_specificity": "Peripheral nervous system injury models (experimental, not human).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:08.720498+00:00"}
{"study_id": 52540, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to review recent developments in osteoarthritis treatment, including the therapeutic potential of glucosamine-chondroitin combinations.", "results_summary": "The study highlights a continued focus on glucosamine-chondroitin as a therapeutic agent for osteoarthritis, suggesting potential benefits, though specific efficacy details are not provided. The abstract also notes emerging interest in biologic therapies and strontium ranelate.", "population_specificity": "Patients with osteoarthritis at the knee, hip, and hand joints.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:09.672412+00:00"}
{"study_id": 52544, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of chondroitin sulfate proteoglycans as axonal-growth inhibitors in peripheral nerve regeneration and the potential of pharmacological therapies to overcome these inhibitory signals.", "results_summary": "The study highlights that chondroitin sulfate proteoglycans act as inhibitors to axonal regeneration in peripheral nerves, with motor neurons being more affected than sensory neurons when the ROCK signaling pathway is inhibited. The findings suggest potential therapeutic targets to improve nerve regeneration outcomes.", "population_specificity": "Peripheral nerve injury models (specific human or animal population not detailed in the abstract).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:10.419209+00:00"}
{"study_id": 52542, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether a dietary supplement containing chondroitin sulfate, among other ingredients, could improve facial photoaging by assessing skin parameters and serum biomarkers.", "results_summary": "The study found that the dietary supplement (VISCODERM Pearls) significantly improved photoaging scores, skin hydration, sebum, and tonicity, along with favorable changes in serum biomarkers like increased fibronectin and hyaluronic acid and decreased neutrophil elastase 2 and carbonylated proteins compared to placebo.", "population_specificity": "Women aged 43.6 \u00b1 1.2 years with moderate to severe facial photoaging.", "effective_dosage": "Not specified for chondroitin sulfate alone; administered as part of a multi-ingredient supplement twice daily.", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:11.549715+00:00"}
{"study_id": 52543, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of CHST14 and DSE variants in the biosynthesis of chondroitin sulfate (CS)/dermatan sulfate (DS) glycosaminoglycans and their impact on musculocontractural Ehlers-Danlos syndrome (MC-EDS).", "results_summary": "The study identified novel CHST14 and DSE variants causing severe and milder MC-EDS, respectively, and demonstrated impaired glycanation of decorin in fibroblasts, with complete CS replacement in D4ST1-deficiency and partial DS retention in DS-epi1-deficiency. The findings highlight the importance of CS/DS balance for connective tissue integrity and organ development.", "population_specificity": "Patients with MC-EDS caused by CHST14 or DSE variants.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:11.762573+00:00"}
{"study_id": 52545, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the role of chondroitin sulfate (CS) in the treatment of knee osteoarthritis (OA) and compare its efficacy and safety with other treatment modalities.", "results_summary": "The study found that chondroitin sulfate is considered part of the symptomatic slow-acting drugs for osteoarthritis (SySADOAs), with discrepancies in guidelines reflecting geographical differences in drug availability and prescription practices. The consensus highlighted the need for harmonized recommendations, including CS, for optimal OA management.", "population_specificity": "Patients with knee osteoarthritis, primarily in European and US settings.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:12.556289+00:00"}
{"study_id": 52547, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of chondroitin, among other nutraceuticals and viscosupplementation agents, in managing osteoarthritis symptoms and progression.", "results_summary": "The abstract does not provide specific results for chondroitin alone, but it mentions that glucosamine sulfate (often combined with chondroitin) has a moderate effect on pain management, while no evidence supports that nutraceuticals influence osteoarthritis's natural progression.", "population_specificity": "Patients with osteoarthritis (knee and hip mentioned).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:14.874574+00:00"}
{"study_id": 52546, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of a glucosamine-chondroitin sulfate combination on pain, joint function, and inflammatory markers in patients with temporomandibular joint (TMJ) internal derangements.", "results_summary": "The glucosamine-chondroitin combination significantly improved maximum mouth opening (MMO) and reduced synovial fluid IL-1\u03b2 and IL-6 levels compared to tramadol, though TNF-\u03b1 and PGE2 changes were not statistically significant. Pain reduction was similar between the two groups.", "population_specificity": "31 patients with TMJ disc displacement and joint tenderness.", "effective_dosage": "1200 mg chondroitin sulfate combined with 1500 mg glucosamine (frequency not specified).", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:15.368142+00:00"}
{"study_id": 52548, "supplement_id": 1021, "safety_score": "85", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the benefit and harm of oral chondroitin for treating osteoarthritis compared with placebo or other oral medications.", "results_summary": "Chondroitin showed statistically significant and clinically meaningful improvements in pain and Lequesne's index in short-term studies, with a lower risk of serious adverse events compared to placebo. However, results were heterogeneous, and evidence quality varied from low to high depending on the outcome.", "population_specificity": "Adults with osteoarthritis in any joint, predominantly knee OA, with few studies on hip and hand OA.", "effective_dosage": "Not specified", "study_duration": "Varied from 1 month to 3 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:18.268006+00:00"}
{"study_id": 52550, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers compared the effectiveness of Meriva+glucosamine versus chondroitin sulphate+glucosamine in improving outcomes for patients with grade 1-2 knee osteoarthritis.", "results_summary": "The study found that Meriva+glucosamine resulted in significantly higher Karnofsky Index and WOMAC scores, as well as improved walking distance, compared to chondroitin+glucosamine. The need for concomitant drugs and medical attention decreased more in the Meriva+glucosamine group.", "population_specificity": "124 patients with grade 1-2 osteoarthritis of the knee.", "effective_dosage": "Not specified", "study_duration": "4 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:19.635352+00:00"}
{"study_id": 52552, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 20, "study_goal": "The researchers aimed to explore the potential effects of chondroitin sulfate as part of a broader investigation into various \"fancy molecules\" for treating IBD.", "results_summary": "The abstract mentions chondroitin sulfate among other substances tested in patients with claims of success, but notes that controlled data in appropriate studies are lacking. No specific results for chondroitin are provided.", "population_specificity": "Patients with inflammatory bowel disease (IBD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:19.869542+00:00"}
{"study_id": 52551, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to understand the mechanism of action of sodium ferulate and a polysaccharidic fraction (containing chondroitin sulfate) from Angelica sinensis in preventing cartilage destruction and promoting repair in osteoarthritis.", "results_summary": "Sodium ferulate showed anti-inflammatory and anti-apoptotic effects by inhibiting the TNF/TNFR pathway, while the polysaccharidic fraction promoted proteoglycan biosynthesis in cartilage by stimulating UDP-glycosyltransferases, suggesting combined benefits for osteoarthritis treatment.", "population_specificity": "Animal models of osteoarthritis and human chondrocytes stimulated by Interleukine-1\u03b2.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:21.330420+00:00"}
{"study_id": 52553, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to develop consensus recommendations for the early identification and management of spinal cord compression, anesthesia, surgical practices, and cardiac/respiratory management in patients with Morquio A syndrome.", "results_summary": "The study did not directly assess Chondroitin's effects but highlighted its faulty catabolism in Morquio A syndrome due to GALNS deficiency, leading to tissue and organ dysfunction.", "population_specificity": "Patients with Morquio A syndrome (a form of mucopolysaccharidosis IVA).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:21.670546+00:00"}
{"study_id": 52554, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review literature on the role of ECM molecules, including chondroitin sulfate proteoglycans, in neuropsychiatric disorders such as addiction and schizophrenia.", "results_summary": "The abstract suggests that ECM molecules, including chondroitin sulfate proteoglycans, may be involved in neuropsychiatric disorders, but it does not provide specific findings on chondroitin's effects.", "population_specificity": "Preclinical and clinical research (no specific population detailed).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:22.932362+00:00"}
{"study_id": 52555, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of chondroitin sulfate proteoglycans in synaptic stabilization, memory formation, and their implications in neurodegenerative disorders like Alzheimer's disease.", "results_summary": "The study found that chondroitin sulfate proteoglycans in perineuronal nets stabilize synapses and memory trails but may limit plasticity and tissue recovery. Age-related changes in the extracellular matrix, including chondroitin, are linked to neurodegenerative disorders.", "population_specificity": "Not specified (general discussion of brain extracellular matrix and neurodegenerative disorders).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:24.053817+00:00"}
{"study_id": 52556, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the structural and functional diversity of chondroitin sulfate (CS) chains and their role in biological processes, focusing on the concept of \"sugar remodeling\" as a method to study CS function.", "results_summary": "The study highlights that CS chains exhibit significant structural variability due to enzymatic modifications like sulfation, which influences their biological functions, including cell adhesion, proliferation, and neurite outgrowth. Sugar remodeling is presented as a promising approach to further understand and manipulate CS chain functions.", "population_specificity": "Not specified (general biological and cellular contexts)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:28.586328+00:00"}
{"study_id": 52557, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 70, "study_goal": "The researchers aimed to review the pathogenesis, diagnosis, and current/future therapies of Morquio A syndrome, focusing on the role of chondroitin-6-sulfate accumulation in cartilage disruption.", "results_summary": "The abstract discusses the accumulation of chondroitin-6-sulfate in Morquio A syndrome, leading to abnormal chondrogenesis and skeletal dysplasia, but does not report specific therapeutic effects or outcomes related to chondroitin supplementation.", "population_specificity": "Patients with Morquio A syndrome (a lysosomal storage disorder).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:29.041903+00:00"}
{"study_id": 52558, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to review the biological applications of chondroitinase, its potential as a drug candidate, and the need for improved delivery systems and distribution studies.", "results_summary": "The abstract highlights chondroitinase's potential in treating conditions with elevated CSPGs (e.g., spinal cord injury, vitreous attachment, cancer) based on animal studies, but notes a lack of clinical translation due to insufficient delivery systems and distribution research.", "population_specificity": "Not specified (review of preclinical and microbial studies).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:29.073167+00:00"}
{"study_id": 52560, "supplement_id": 1021, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to review the structure, biological activity, and therapeutic potential of marine-derived glycosaminoglycan analogs, including fucosylated chondroitin sulfate, focusing on anticoagulant and anti-inflammatory effects.", "results_summary": "The study found that fucosylated chondroitin sulfate from sea cucumbers exhibited significant anticoagulant activity after oral administration and high anti-P- and L-selectin activities, with therapeutic value confirmed in animal models of thrombosis, inflammation, and metastasis.", "population_specificity": "Animal models (not specified further)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:30.069302+00:00"}
{"study_id": 52559, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the role of chondroitin sulfate proteoglycans (CSPGs) as inhibitors of nerve regeneration and explore therapeutic strategies to overcome their inhibitory effects.", "results_summary": "The study found that CSPGs, while important in normal central nervous system function, form barriers to regeneration after injury or disease. It highlights the role of inflammation in stimulating CSPG expression and discusses potential therapeutic approaches to promote nerve repair.", "population_specificity": "Central nervous system (general, not specific to humans or animals)", "effective_dosage": "Not available", "study_duration": "Not applicable (review study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:30.237755+00:00"}
{"study_id": 52562, "supplement_id": 1021, "safety_score": "75", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the safety and efficacy of elosulfase alfa (a treatment targeting chondroitin-6-sulfate accumulation) in patients with mucopolysaccharidosis type IVA (MPS IVA).", "results_summary": "Elosulfase alfa significantly improved urinary keratan sulfate levels and endurance (measured by 6-minute walk test distance) in patients with MPS IVA. Infusion-associated reactions were generally mild to moderate and manageable.", "population_specificity": "Children and adults aged \u22655 years with MPS IVA.", "effective_dosage": "2 mg/kg/week (intravenous)", "study_duration": "24 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:33.430626+00:00"}
{"study_id": 52561, "supplement_id": 1021, "safety_score": "85", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to summarize current knowledge on the structure, properties, pharmacological activity, and mechanisms of action of Chondroitin sulfate (CS)/Condrosulf(\u00ae) in osteoarthritis treatment, including its potential as a structure-modifying agent.", "results_summary": "The study found that CS/Condrosulf(\u00ae) is effective as a SYSADOA and S/DMOAD, with clinical trials and meta-analyses supporting its pharmacological activity in osteoarthritis. It also highlighted future potential for using MRI and biomarkers to advance its application.", "population_specificity": "Patients with osteoarthritis (OA).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:33.614934+00:00"}
{"study_id": 52565, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of chondroitin sulfate in ovarian cancer tumorigenesis, including its functions in tumor growth, angiogenesis, dissemination, and immunosilencing, and its potential as a diagnostic and therapeutic target.", "results_summary": "The study found that chondroitin sulfate plays a key role in ovarian cancer progression by interacting with various ligands, influencing tumor growth, angiogenesis, and immune evasion. It suggests chondroitin sulfate as a promising target for future diagnostic and therapeutic strategies.", "population_specificity": "Ovarian cancer (not specified if human or animal model).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:38.450284+00:00"}
{"study_id": 52564, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the diagnostic utility of chondroitin sulfate (CS) levels versus alkaline phosphatase (ALP) levels in evaluating the severity of chronic periodontitis.", "results_summary": "The study found that CS levels were significantly higher in moderately and severely destructive periodontal sites compared to non-destructive or slightly destructive sites, and CS levels correlated more strongly with periodontal disease parameters than ALP levels. The results suggest CS is a better diagnostic marker for assessing periodontitis severity.", "population_specificity": "Patients with gingivitis (n=10), chronic periodontitis (n=33), and healthy volunteers (n=10).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:38.478976+00:00"}
{"study_id": 52563, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to understand the molecular mechanisms by which chondroitin sulfate proteoglycans (CSPGs) inhibit axon regeneration and identify potential therapeutic targets to overcome scar-mediated inhibition after CNS injuries.", "results_summary": "The study found that CSPGs inhibit axon growth through multiple mechanisms, including binding to high-affinity receptors like protein tyrosine phosphatase \u03c3 and LAR, as well as Nogo receptors 1 and 3. These findings highlight the complexity of CSPG-mediated inhibition and suggest the need for novel therapies targeting these receptors to promote axon regeneration.", "population_specificity": "The study focuses on the general mechanisms of CSPG inhibition in CNS injuries, without specifying a particular human or animal population.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:38.514303+00:00"}
{"study_id": 52567, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to develop a treatment algorithm for osteoarthritis, including the role of chondroitin sulfate as part of chronic Symptomatic Slow-Acting Drugs for OA.", "results_summary": "Chondroitin sulfate was included as part of the pharmacological background therapy for osteoarthritis, alongside glucosamine sulfate and paracetamol, suggesting its efficacy in symptom management. The algorithm positions it as a first-line pharmacological intervention for persistent symptoms.", "population_specificity": "Patients with knee osteoarthritis, applicable in Europe and internationally.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:38.928877+00:00"}
{"study_id": 52566, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to investigate whether germline polymorphisms in genes related to pericyte maturation, including CSPG4 (chondroitin sulfate proteoglycan NG2), could predict bevacizumab efficacy in metastatic colorectal cancer (mCRC) patients.", "results_summary": "The study found that CSPG4 rs1127648 was associated with differences in progression-free survival (PFS), though this significance was lost in multivariate analysis. The biomarker value of SNPs, including those related to CSPG4, depended on primary tumor location.", "population_specificity": "424 patients with metastatic colorectal cancer treated first-line with FOLFIRI+bevacizumab in two clinical trials.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:39.034336+00:00"}
{"study_id": 52549, "supplement_id": 1021, "safety_score": "85", "efficacy_score": 90, "quality_score": 95, "study_goal": "To compare the efficacy and safety of chondroitin sulfate plus glucosamine hydrochloride (CS+GH) versus celecoxib in patients with knee osteoarthritis and severe pain.", "results_summary": "CS+GH showed comparable efficacy to celecoxib in reducing pain, stiffness, functional limitation, and joint swelling/effusion after 6 months, with no significant differences in adverse events between the groups. Both treatments achieved a >50% reduction in joint swelling and met OMERACT-OARSI criteria in ~80% of patients.", "population_specificity": "606 patients with Kellgren and Lawrence grades 2-3 knee osteoarthritis and moderate-to-severe pain (WOMAC score \u2265301).", "effective_dosage": "400 mg CS plus 500 mg GH three times a day.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:39.518529+00:00"}
{"study_id": 52569, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of chondroitin sulfate and glucosamine sulfate on joint metabolism and their role in managing osteoarthritis (OA).", "results_summary": "Chondroitin sulfate and glucosamine sulfate improved type II collagen and proteoglycan synthesis, reduced pro-inflammatory mediators and proteases, and enhanced the anabolic/catabolic balance of cartilage. Clinical trials showed small but significant benefits in reducing joint space narrowing and improving pain and function in OA patients.", "population_specificity": "Patients with knee and hip osteoarthritis (OA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:42.410168+00:00"}
{"study_id": 52568, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to determine whether chondroitin sulfate could preserve articular cartilage and delay osteoarthritis progression in the knee.", "results_summary": "Chondroitin sulfate showed a significant reduction in cartilage loss in 3 out of 4 studies compared to placebo, indicating potential chondroprotective effects. The results suggest it may be effective in slowing osteoarthritis progression.", "population_specificity": "Patients with or at risk for osteoarthritis of the knee.", "effective_dosage": "Not specified", "study_duration": "\u226512 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:42.903407+00:00"}
{"study_id": 52572, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to review existing literature on intravesical treatments for bladder pain syndrome/interstitial cystitis (BPS/IC), including chondroitin sulfate, among other drugs.", "results_summary": "The abstract mentions chondroitin sulfate as one of several intravesical drugs studied for BPS/IC but does not provide specific findings regarding its efficacy or safety.", "population_specificity": "Patients with bladder pain syndrome/interstitial cystitis (BPS/IC).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:46.255013+00:00"}
{"study_id": 52573, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were not attempting to determine anything about Chondroitin, as the review explicitly ignores data on nutraceuticals like Chondroitin.", "results_summary": "The study did not examine Chondroitin's effects, as it focused on other dietary factors for osteoarthritis prevention and progression.", "population_specificity": "Not specified (general discussion of osteoarthritis risk factors)", "effective_dosage": "Not available", "study_duration": "Not applicable", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:46.383882+00:00"}
{"study_id": 52571, "supplement_id": 1021, "safety_score": "95", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of oral chondroitin sulfate plus glucosamine on repairing articular surfaces in osteoarthritis and their impact on inflammation, pain, and joint function.", "results_summary": "The study found that chondroitin sulfate plus glucosamine reduces pro-inflammatory cytokines, enhances cartilage-specific matrix components, alleviates pain, and partly restores joint function in osteoarthritis patients. It also stabilizes joint space narrowing and reduces new erosive OA cases without reported adverse events.", "population_specificity": "Osteoarthritis (OA) patients", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:46.735871+00:00"}
{"study_id": 52575, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the appropriateness of chondroitin as a treatment for knee osteoarthritis across different clinical sub-phenotypes.", "results_summary": "Chondroitin was classified as a treatment of uncertain appropriateness for specific clinical sub-phenotypes of knee osteoarthritis, indicating mixed or inconclusive evidence regarding its efficacy.", "population_specificity": "Individuals with knee osteoarthritis, stratified into four clinical sub-phenotypes.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:46.760099+00:00"}
{"study_id": 52570, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to compare the effects of avocado-soyabean unsaponifiables (ASU) 300 mg with chondroitin sulphate on osteoarthritis symptoms and adverse events.", "results_summary": "Low-quality evidence from one study (357 participants) suggested no significant differences in symptoms or adverse events between ASU 300 mg and chondroitin sulphate. No serious side effects were reported for any plant product, including chondroitin.", "population_specificity": "People with osteoarthritis.", "effective_dosage": "Not specified for chondroitin sulphate.", "study_duration": "Not specified for chondroitin sulphate.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:47.015492+00:00"}
{"study_id": 52574, "supplement_id": 1021, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effect of amphiphilic polysaccharides-based micelles on enhancing the oral absorption of low molecular weight chondroitin sulfate (LMCS) and identify its transport mechanism across the intestinal barrier.", "results_summary": "The study found that \u03b1-LNA-LMCS micelles significantly enhanced oral absorption and extended elimination half-life in rats, with higher permeability coefficients compared to CS and LMCS. The micelles opened intercellular tight junctions without disrupting monolayer integrity, suggesting improved bioavailability and low cytotoxicity.", "population_specificity": "Rats (in vivo) and Caco-2 cell monolayers (in vitro)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:47.875717+00:00"}
{"study_id": 52577, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine if blood concentrations of chondroitin sulphate could serve as a diagnostic marker for non-alcoholic steatohepatitis (NASH) and staging of non-alcoholic fatty liver disease (NAFLD).", "results_summary": "The study found that chondroitin sulphate blood concentrations are suitable for diagnosing NASH and staging NAFLD. The research also identified serine deficiency in NASH patients and potential therapeutic targets.", "population_specificity": "Patients with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:52.637160+00:00"}
{"study_id": 52576, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of chondroitin sulphate proteoglycans in the extracellular matrix (ECM) and their potential manipulation to promote functional recovery after brain or spinal cord injury.", "results_summary": "The study discusses how chondroitin sulphate proteoglycans in the ECM can restrict plasticity and limit repair after CNS injury, suggesting that modifying these components could enhance recovery. Experimental strategies targeting the ECM, including chondroitin manipulation, are considered for improving functional outcomes.", "population_specificity": "Not specified (theoretical focus on CNS injury models, likely animal or in vitro studies based on context).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:52.870113+00:00"}
{"study_id": 52578, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to identify genetic variants, including those in the chondroitin sulfotransferase family (CHST), associated with gemcitabine response variability in cancer treatment.", "results_summary": "The study found significant associations between gemcitabine response and genetic variants in the CHST family, though the specific role of chondroitin in this response remains unclear.", "population_specificity": "NCI-60 cell lines and 351 pancreatic cancer patients (subset of 135 treated with gemcitabine+placebo).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:55.051789+00:00"}
{"study_id": 52581, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of chondroitin and other structurally similar capsular polysaccharides in bacterial immune evasion and potential therapeutic applications.", "results_summary": "The study found that chondroitin, as a bacterial capsular polysaccharide, mimics mammalian polysaccharides, enabling pathogens to evade immune detection and persist in host tissues. This mechanism suggests potential therapeutic targets for combating antibiotic-resistant infections.", "population_specificity": "Not specified (focus on bacterial pathogens and immune evasion mechanisms).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:55.283979+00:00"}
{"study_id": 52580, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of a fixed combination of hyaluronic acid and chondroitin-sulfate (HA+CS) in adults with non-erosive gastroesophageal reflux symptoms and low response to PPIs.", "results_summary": "The HA+CS combination significantly improved symptoms of heartburn and acid regurgitation compared to placebo, with faster onset of action (\u226430 minutes) and total symptom disappearance in 50% of patients.", "population_specificity": "Adults with non-erosive gastroesophageal reflux symptoms and low response to PPIs.", "effective_dosage": "Four daily doses (specific amount not provided).", "study_duration": "14 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:55.951280+00:00"}
{"study_id": 52579, "supplement_id": 1021, "safety_score": "85", "efficacy_score": 60, "quality_score": 90, "study_goal": "The researchers aimed to determine if chondroitin sulfate, alone or combined with glucosamine, reduces joint space narrowing and pain in people with symptomatic knee osteoarthritis.", "results_summary": "The combination of glucosamine and chondroitin significantly reduced joint space narrowing compared to placebo, but chondroitin alone showed no significant structural effect. All groups, including placebo, reported reduced knee pain, with no significant differences between treatments.", "population_specificity": "Adults aged 45-75 with chronic knee pain and medial tibio-femoral compartment narrowing (retaining >2 mm medial joint space width).", "effective_dosage": "800 mg chondroitin sulfate once daily.", "study_duration": "2 years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:55.957080+00:00"}
{"study_id": 52582, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the role of natural polymers, including chondroitin, in wound and burn management due to their biocompatibility and biodegradability.", "results_summary": "The abstract highlights that chondroitin, as a natural polymer, is extensively used in wound and burn management for its biocompatibility and similarity to human macromolecules, contributing to tissue recovery. However, specific efficacy data for chondroitin alone are not detailed.", "population_specificity": "Patients with wounds and burns (general, not specified further).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:56.086213+00:00"}
{"study_id": 52583, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether chondroitin sulfate is associated with knee bone marrow lesions (BMLs) in asymptomatic pre-osteoarthritis and osteoarthritis populations.", "results_summary": "The study found limited evidence for an association between chondroitin sulfate and knee BMLs, indicating weak or inconclusive effects.", "population_specificity": "Asymptomatic pre-osteoarthritis and osteoarthritis populations with knee bone marrow lesions.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:22:57.131406+00:00"}
{"study_id": 52584, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential of glycosaminoglycan compounds, including chondroitin sulfate, to target synovial inflammation in osteoarthritis.", "results_summary": "Chondroitin sulfate demonstrated effectiveness in controlling cellular infiltration, biochemical mediator release, and angiogenesis in synovial membrane inflammation. It showed complementary anti-inflammatory properties with other GAGs like glucosamine and hyaluronic acid.", "population_specificity": "Osteoarthritis patients (synovial inflammation focus)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:01.199346+00:00"}
{"study_id": 52585, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to compare the efficacy of a biomarine compound (LD-1227) versus a glucosamine/chondroitin sulfate mixture in managing knee osteoarthritis symptoms.", "results_summary": "The study found that LD-1227 outperformed the glucosamine/chondroitin sulfate mixture in improving clinical indexes and reducing NSAID use, with a more significant downregulation of inflammatory cytokines. Chondroitin sulfate showed slower and less pronounced effects compared to LD-1227.", "population_specificity": "60 subjects with mild-moderate knee osteoarthritis.", "effective_dosage": "400 mg chondroitin sulfate (combined with 500 mg glucosamine).", "study_duration": "18 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:02.101682+00:00"}
{"study_id": 52587, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to review the role of ADAMTS proteoglycanases in CNS injuries and their potential as therapeutic targets.", "results_summary": "The study found that ADAMTS proteoglycanases are deregulated in acute CNS injuries and may mediate synaptic plasticity, neurorepair, angiogenesis, and inflammation, suggesting their potential as therapeutic targets.", "population_specificity": "Not specified (review of existing literature on CNS injuries).", "effective_dosage": "Not available", "study_duration": "Not applicable (review study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:03.481664+00:00"}
{"study_id": 52586, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of EXTL2 in glycosaminoglycan (GAG) biosynthesis and its impact on tissue homeostasis under pathological conditions, not specifically Chondroitin.", "results_summary": "The study found that EXTL2-knockout mice exhibited impaired liver regeneration and enhanced vascular smooth muscle cell mineralization under induced pathological conditions, linked to altered GAG biosynthesis. These changes were associated with disrupted signaling pathways (hepatocyte-growth-factor and bone-morphogenetic-protein).", "population_specificity": "EXTL2-knockout mice and wild-type mice.", "effective_dosage": "Not mentioned", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:03.919231+00:00"}
{"study_id": 52590, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to explore the role of chondroitin sulfate in the high-affinity binding of midkine (MK) to its receptor, PTP\u03b6.", "results_summary": "The study identified chondroitin sulfate as essential for high-affinity binding between MK and PTP\u03b6, highlighting its role in MK signaling pathways. No direct effects or outcomes of chondroitin supplementation were discussed.", "population_specificity": "Not specified (focus was on molecular mechanisms).", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:04.854874+00:00"}
{"study_id": 52588, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the clinical applications of glycosaminoglycans (GAGs), including chondroitin sulphate, in treating chronic forms of cystitis.", "results_summary": "The study found that GAG replenishment therapy, including chondroitin sulphate, is widely accepted for treating various bladder conditions, with encouraging evidence, though more robust clinical trials are needed to confirm its exact role.", "population_specificity": "Patients with chronic cystitis, including interstitial cystitis/bladder pain syndrome (IC/BPS), recurrent UTIs, radiation/chemo-immunotherapy cystitis, and overactive bladder (OAB).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:05.197283+00:00"}
{"study_id": 52591, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to summarize glycan biomarkers, including chondroitin/dermatan sulfate, for diagnosing and monitoring mucopolysaccharidoses (MPS) and evaluating therapies.", "results_summary": "The study highlighted advances in analyzing non-reducing terminal glycans as biomarkers for MPS diagnosis and therapy monitoring, using enzymatic digestion and mass spectrometry, but did not specifically report chondroitin's effects.", "population_specificity": "Patients with mucopolysaccharidoses (MPS), animal models, and newborn infants (via dried blood spots).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:05.723255+00:00"}
{"study_id": 52589, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the role of chondroitin sulfate proteoglycans (CSPGs) and perineuronal nets (PNNs) in regulating neuronal plasticity and their potential therapeutic applications in conditions like regeneration, stroke, amblyopia, epileptogenesis, and dementia.", "results_summary": "The study found that CSPGs and PNNs restrict neuronal plasticity, and their enzymatic degradation or destabilization enhances neuronal activity and plasticity, particularly after central nervous system injury. The review highlights the therapeutic potential of manipulating these structures for functional recovery in various neurological conditions.", "population_specificity": "Mammalian systems (not human-specific).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:06.025918+00:00"}
{"study_id": 52592, "supplement_id": 1021, "safety_score": "85", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the safety, efficacy, and structural effects of chondroitin in the treatment of osteoarthritis.", "results_summary": "The study found that chondroitin has a good safety profile and may induce key intermediates in the OA pathophysiological process. Clinical trials reported symptomatic and structure-modifying effects, though results were conflicting and questionable.", "population_specificity": "Osteoarthritis patients", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:08.825915+00:00"}
{"study_id": 52593, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to review the consequences of the foreign body response (FBR) to chronic electrode implants and explore recent developments to control and limit its progression.", "results_summary": "The abstract discusses the impact of FBR on electrode implants, including neuronal loss and glial sheath formation, and reviews potential solutions such as material choice, electrode architecture, and biological interventions like anti-inflammatory compounds. It does not specifically address Chondroitin.", "population_specificity": "Not specified (focus is on chronic electrode implants and tissue response).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:10.960522+00:00"}
{"study_id": 52596, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of chondroitin sulfate (CS) in CNS development, injury, and disorders, focusing on the relationship between sulfation patterns and functionality.", "results_summary": "The study highlights the importance of CS in neurological processes like neuronal growth, regeneration, and plasticity but notes challenges in defining the link between specific sulfation patterns and functionality. Emerging tools may improve understanding of CS's therapeutic potential for CNS disorders.", "population_specificity": "Central nervous system (CNS) processes (not human-specific).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:12.826870+00:00"}
{"study_id": 52595, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to develop a high-throughput method for detecting glycosaminoglycans (including chondroitin sulfate) in blood samples to diagnose mucopolysaccharidoses (MPS) and monitor therapeutic efficacy.", "results_summary": "The study found that combined measurements of DS, HS, and KS (including chondroitin sulfate) were highly sensitive and specific for detecting MPS, with 100% sensitivity and 98.5-99.4% specificity. The method also showed potential for monitoring therapeutic efficacy.", "population_specificity": "Newborns (MPS I, II, and VII patients vs. healthy controls)", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:12.855507+00:00"}
{"study_id": 52597, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 50, "study_goal": "The researchers aimed to explore the use of chondroitin sulfate as part of complementary and alternative medicine (CAM) interventions for mast cell-related atopic conditions.", "results_summary": "The abstract mentions anecdotal clinical observations and some in vitro and in vivo studies supporting the use of chondroitin sulfate, but it does not provide specific results regarding its efficacy or safety.", "population_specificity": "Not specified (general mention of atopic conditions involving mast cells).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:13.109865+00:00"}
{"study_id": 52599, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether intravesical therapy with hyaluronic acid and chondroitin sulfate is more effective than antibiotic therapy in reducing episodes and symptoms of recurrent urinary tract infections.", "results_summary": "The study found that 72.7% of patients treated with HA-CS and 75% treated with HA-CS plus fosfomycin were event-free at follow-up, compared to only 30.4% in the fosfomycin-only group, indicating HA-CS therapy was more effective.", "population_specificity": "Women affected by recurrent urinary tract infections.", "effective_dosage": "Not specified", "study_duration": "6- to 12-month follow-up", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:14.471785+00:00"}
{"study_id": 52600, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare chondroitin sulphate (CS) levels, tooth movement rates, and pain levels in patients undergoing orthodontic treatment with two different force magnitudes (70 g and 120 g).", "results_summary": "CS levels increased significantly during orthodontic force application, but no significant difference was found between 70 g and 120 g forces. Tooth movement rates were similar for both forces, but 120 g caused significantly more pain than 70 g.", "population_specificity": "16 patients (6 males, 10 females; aged 16.91 \u00b1 2.99 years) with class I malocclusion requiring orthodontic treatment with first premolar extractions.", "effective_dosage": "Not specified (study measured endogenous CS levels in GCF, not administered as a supplement).", "study_duration": "Not explicitly stated (measurements taken before and during orthodontic movement, likely weeks based on context).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:17.051634+00:00"}
{"study_id": 52601, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the role of versican, particularly its chondroitin sulfate side chains, in cancer development and potential therapeutic targeting.", "results_summary": "The abstract highlights that versican, through its chondroitin sulfate side chains, regulates cellular processes like adhesion, proliferation, and metastasis, contributing to cancer progression. Therapeutic targeting of versican in malignant tumors is discussed, but specific outcomes related to chondroitin are not detailed.", "population_specificity": "Not specified (review of existing literature on versican in cancer).", "effective_dosage": "Not available", "study_duration": "Not applicable (review study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:17.338501+00:00"}
{"study_id": 52602, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to determine whether the Ext mutation in HME patients affects HS and CS structures and amounts in blood samples, potentially using HS/CS ratios as a diagnostic biomarker.", "results_summary": "The study found that while HS structures in HME patients were similar to controls, HS amounts were decreased, and HS/CS ratios were nearly half those of healthy individuals, suggesting potential diagnostic utility.", "population_specificity": "Patients with hereditary multiple exostoses (HME) and healthy individuals.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:19.704327+00:00"}
{"study_id": 52603, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the properties of an embroidered and surface-coated polycaprolactone-co-lactide scaffold as a potential bone graft substitute for large bone defects.", "results_summary": "The study systematically assessed the scaffold's design, fabrication, properties, and surface modification, followed by in vitro and in vivo analysis using orthotopic implantation models in small and large animals.", "population_specificity": "Small and large animal models (specific species not mentioned).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:20.943447+00:00"}
{"study_id": 52605, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the efficacy of disease-modifying osteoarthritis drugs (DMOADs), including chondroitin, in treating osteoarthritis.", "results_summary": "The study found that chondroitin sulfate is recommended by OARSI guidelines as a DMOAD, suggesting it has efficacy in modifying osteoarthritis progression. The abstract highlights the need for further clinical studies to confirm benefits across different disease stages.", "population_specificity": "Patients with osteoarthritis (specific demographics not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:21.293631+00:00"}
{"study_id": 52604, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to review the properties and applications of nanogels, including those made with methacrylated chondroitin sulfate, for drug delivery and imaging in cancer.", "results_summary": "The abstract highlights that nanogels, including those using methacrylated chondroitin sulfate, are versatile for drug encapsulation, controlled release, and targeted delivery, with potential applications in cancer therapy and imaging.", "population_specificity": "Not specified (review of nanogel applications, not a clinical study).", "effective_dosage": "Not mentioned.", "study_duration": "Not applicable (review article).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:21.886267+00:00"}
{"study_id": 52606, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of Rho pathway inhibition, including the effects of chondroitin sulfate proteoglycans, in promoting neuroprotection and axonal regeneration after spinal cord injury.", "results_summary": "The study found that Rho inhibition, including the role of chondroitin sulfate proteoglycans, promotes axonal sprouting and locomotor recovery in animal models of spinal cord injury, with promising results from a phase I/IIa clinical trial of the Rho inhibitor Cethrin.", "population_specificity": "Animal models (mice) and human participants in a phase I/IIa clinical trial for spinal cord injury.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:24.712062+00:00"}
{"study_id": 52608, "supplement_id": 1021, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to summarize the mechanisms of action and clinical efficacy of pharmaceutical-grade chondroitin sulfate in osteoarthritis, based on existing literature.", "results_summary": "Chondroitin sulfate showed beneficial effects on cartilage metabolism, reducing inflammation and improving anabolic/catabolic balance. Clinical trials reported pain relief, functional improvement, and a modest reduction in joint space width decline in knee osteoarthritis.", "population_specificity": "Patients with osteoarthritis (knee and hip).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:25.891176+00:00"}
{"study_id": 52598, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the history, clinical manifestations, and diagnostic methods of Mucopolysaccharidosis type IVA (MPS IVA), focusing on the role of chondroitin-6-sulfate (C6S) accumulation due to GALNS enzyme deficiency.", "results_summary": "The study found that MPS IVA results from impaired catabolism of C6S and keratan sulfate, leading to skeletal dysplasia and multi-system abnormalities. Diagnosis relies on clinical examination, enzyme activity assessment, and genetic sequencing.", "population_specificity": "Individuals with Mucopolysaccharidosis type IVA (MPS IVA).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:25.891799+00:00"}
{"study_id": 52607, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to examine the role of proteoglycans, including chondroitin sulfate, in glioblastoma progression and their association with receptor tyrosine kinase signaling.", "results_summary": "The study found that proteoglycans, including chondroitin sulfate, play critical roles in regulating oncogenic pathways and tumor-microenvironment interactions in glioblastoma, with specific alterations linked to changes in receptor tyrosine kinases.", "population_specificity": "Human glioblastoma patients (data from The Cancer Genome Atlas).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:25.944623+00:00"}
{"study_id": 52609, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effect of intravesical HA and HA-CS combination therapy on recurrent bacterial cystitis in adult women, focusing on UTI recurrence rates and symptom improvement.", "results_summary": "The study found that HA-CS therapy significantly reduced UTI recurrence rates, prolonged the time between infections, and improved PUF symptom scores, though it did not significantly affect 3-day voids.", "population_specificity": "Adult women with recurrent bacterial cystitis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:28.519913+00:00"}
{"study_id": 52610, "supplement_id": 1021, "safety_score": "85", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to evaluate whether glucosamine-sulfate and chondroitin-sulfate could alleviate joint pain and stiffness in postmenopausal women with early-stage breast cancer experiencing AI-induced arthralgias.", "results_summary": "The study found that 46% of patients improved according to OMERACT-OARSI criteria, with significant improvements in pain, function, and stiffness as measured by WOMAC, M-SACRAH, and BPI. Side effects were minimal, and estradiol levels remained unchanged.", "population_specificity": "Postmenopausal women with early-stage breast cancer experiencing moderate-to-severe joint pain after initiating aromatase inhibitors.", "effective_dosage": "1,200 mg/day chondroitin-sulfate", "study_duration": "24 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:30.532082+00:00"}
{"study_id": 52611, "supplement_id": 1021, "safety_score": "85", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to compare the efficacy and safety of a single daily 1200 mg dose of chondroitin sulfate versus three daily 400 mg doses and placebo in patients with knee osteoarthritis.", "results_summary": "The study found no significant difference in efficacy or safety between the single 1200 mg dose and three 400 mg doses of chondroitin sulfate. Both treatment groups showed significant improvement in pain and function compared to placebo after 3 months.", "population_specificity": "Patients over 45 years with knee osteoarthritis (Lequesne index \u2265 7 and pain \u2265 40 mm on VAS).", "effective_dosage": "1200 mg once daily (sachet) or 400 mg three times daily (capsules).", "study_duration": "3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:31.444354+00:00"}
{"study_id": 52612, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to identify proteins secreted by cartilage cells under proinflammatory stimuli (IL-1\u03b2) that are regulated by Chondroitin sulfate (CS) and to explore its anti-inflammatory, anti-catabolic, and anti-angiogenic properties.", "results_summary": "CS modulated 18 proteins in chondrocyte secretomes, reducing inflammation by decreasing complement components and increasing anti-inflammatory proteins like TSG6, which correlated with reduced MMP activation. CS also increased thrombospondin-1, an angiogenesis inhibitor, suggesting potential therapeutic benefits for osteoarthritis.", "population_specificity": "Human articular chondrocytes from three normal cartilages.", "effective_dosage": "200 \u00b5g/ml CS pretreatment.", "study_duration": "48 hours post-stimulation.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:31.628909+00:00"}
{"study_id": 52613, "supplement_id": 1021, "safety_score": "90", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy and safety of chondroitin as a nutraceutical treatment for osteoarthritis, focusing on pain relief, functional improvement, and joint structure preservation.", "results_summary": "Chondroitin showed significant improvements in pain and functional indices in some studies, along with reduced joint space width loss, but results were inconsistent across trials. The safety profile was consistently good, with no significant tolerance issues reported.", "population_specificity": "Patients with osteoarthritis.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:33.026918+00:00"}
{"study_id": 52616, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to describe gender-specific correlates of complementary and alternative medicine (CAM) use, including chondroitin sulfate, among individuals with radiographically confirmed knee osteoarthritis.", "results_summary": "The study found that chondroitin sulfate use was common (24.8% in women, 25.7% in men) and did not differ significantly by gender. No specific efficacy outcomes for chondroitin were reported.", "population_specificity": "2,679 women and men with radiographic tibiofemoral osteoarthritis in at least one knee.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:34.440534+00:00"}
{"study_id": 52615, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to understand the structural and functional mechanisms by which chondroitin sulfate proteoglycan (CSPG) interacts with PTP\u03c3 to regulate neural regeneration.", "results_summary": "The study found that CSPG, deposited at neural injury sites, inhibits neural regeneration and axonal growth via PTP\u03c3. The crystal structure of PTP\u03c3 revealed a glycan binding site that interacts with CSPG, providing insights into therapeutic opportunities for neural regeneration.", "population_specificity": "Neural injury models (e.g., stroke) and neural transplantation contexts.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:34.851186+00:00"}
{"study_id": 52614, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the effects of 1.6% hyaluronic acid/4.0% chondroitin sulfate versus 2.0% hydroxypropylmethylcellulose during phacoemulsification, focusing on surgical efficiency and corneal endothelial protection.", "results_summary": "The study found that 1.6% hyaluronic acid/4.0% chondroitin sulfate was easier to remove, required less material, and resulted in better best-corrected visual acuity at 24 hours post-operation compared to hydroxypropylmethylcellulose. Additionally, it significantly preserved corneal endothelial cell count.", "population_specificity": "39 patients (78 eyes) undergoing phacoemulsification.", "effective_dosage": "4.0% chondroitin sulfate combined with 1.6% hyaluronic acid (single intraoperative use).", "study_duration": "Follow-up assessments up to 6 months post-operation.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:37.777699+00:00"}
{"study_id": 52617, "supplement_id": 1021, "safety_score": "90", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to assess the clinical efficacy and safety of intra-articular injections combining hyaluronic acid and chondroitin sulphate in treating knee osteoarthrosis.", "results_summary": "The study found reductions in pain and functional impairment, with the most significant improvements observed at follow-up visits. Although statistical significance was not achieved due to small sample size, trends toward improvement were noted in ultrasound assessments and biomarkers, with no clinically relevant adverse effects reported.", "population_specificity": "Thirty outpatients with knee osteoarthrosis.", "effective_dosage": "Administered 3 times on a weekly basis (frequency specified, exact dosage not provided).", "study_duration": "3 weeks (with follow-up at 6 and 12 weeks after the first injection).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:39.806829+00:00"}
{"study_id": 52618, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to understand the molecular mechanisms by which Chondroitin sulfate proteoglycans (CSPGs) inhibit axon regeneration in the central nervous system (CNS) and explore potential therapeutic targets to overcome this inhibition.", "results_summary": "The study found that CSPGs inhibit axon regeneration through interactions with specific receptors (PTP\u03c3, LAR, NgR1, and NgR3), making them potent therapeutic targets. Enzymatic digestion with chondroitinase ABC (ChABC) is currently the main in vivo approach, but its limitations highlight the need for alternative therapies.", "population_specificity": "Adult mammals with CNS injuries, particularly spinal cord injury (SCI).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:40.226943+00:00"}
{"study_id": 52620, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the correlation between clinical symptoms and cartilage volume changes in knee osteoarthritis patients treated with Structum\u00ae (Chondroitin) over 48 weeks using MRI.", "results_summary": "The Structum\u00ae group showed an increase in total cartilage volume (+180 mm\u00b3) compared to a loss in the placebo group (-46 mm\u00b3), though no significant differences were observed for other MRI parameters or symptom correlations. The study suggests a potential structure-modifying effect of Structum\u00ae.", "population_specificity": "Symptomatic knee osteoarthritis patients aged 50-75 years with Kellgren-Lawrence grade 2 or 3.", "effective_dosage": "500 mg twice daily", "study_duration": "48 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:41.209532+00:00"}
{"study_id": 52619, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the efficacy of intravesical GAG layer replenishment, specifically chondroitin sulphate, for conditions like interstitial cystitis, overactive bladder, radiation cystitis, and recurrent UTIs.", "results_summary": "One randomized study showed clear benefit for OAB patients using chondroitin sulphate 0.2%, while another study with 2.0% chondroitin sulphate failed to show statistically significant evidence due to being underpowered. Overall, limited randomized controlled studies support the efficacy of intravesical GAG therapy, with chondroitin sulphate 0.2% being favored.", "population_specificity": "Patients with interstitial cystitis, overactive bladder, radiation cystitis, and recurrent UTIs.", "effective_dosage": "0.2% and 2.0% chondroitin sulphate (specific frequency not mentioned).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:42.258554+00:00"}
{"study_id": 52622, "supplement_id": 1021, "safety_score": "85", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to evaluate whether the combination of glucosamine and chondroitin alleviates disease progression or pain in individuals with mild to moderate knee osteoarthritis.", "results_summary": "The study found mixed results regarding the effectiveness of glucosamine and chondroitin, with some questioning their benefits due to factors like incorrect dosing and suboptimal compound manufacture. However, the agents were considered safe with minor adverse effects reported.", "population_specificity": "Individuals with mild to moderate knee osteoarthritis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:42.314539+00:00"}
{"study_id": 52621, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to review the role of chondroitin sulfate proteoglycans in astrogliosis and glial scarring following spinal cord injury, and explore therapeutic strategies targeting these mechanisms.", "results_summary": "The study found that chondroitin sulfate proteoglycans contribute to inhibitory effects in spinal cord injury by promoting glial scarring, but recent evidence suggests astrogliosis and scar formation may have reparative roles depending on timing and context. Therapeutic strategies targeting astrocyte reactivity and scar formation are being explored.", "population_specificity": "Spinal cord injury models (not specified if human or animal).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:42.612661+00:00"}
{"study_id": 52624, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the safety and effectiveness of intravesical 2% chondroitin sulfate in women with interstitial cystitis/bladder pain syndrome (IC/BPS).", "results_summary": "Chondroitin sulfate showed minor improvements in symptoms and pain compared to the control group, but the differences were not statistically significant. The study concluded that chondroitin sulfate may offer slight benefits but is not sufficient as monotherapy for IC/BPS.", "population_specificity": "Women diagnosed with interstitial cystitis/bladder pain syndrome (IC/BPS).", "effective_dosage": "20 mL of 2% chondroitin sulfate administered weekly.", "study_duration": "8 weeks of treatment, with follow-up at week 11.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:47.585970+00:00"}
{"study_id": 52630, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the effectiveness of chondroitin, in combination with glucosamine, for treating moderate to severe osteoarthritis.", "results_summary": "The study found that chondroitin, when taken with glucosamine, can be beneficial for moderate to severe osteoarthritis, though the abstract does not specify the extent of improvement. It positions chondroitin as a viable supplement option alongside other treatments like NSAIDs and injections.", "population_specificity": "Patients with moderate to severe osteoarthritis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:50.484440+00:00"}
{"study_id": 52626, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to develop a quantitative flow cytometry assay to evaluate the purity of tumor-infiltrating lymphocyte (TIL) populations by detecting melanoma chondroitin sulfate proteoglycan (MCSP) and other tumor antigens.", "results_summary": "The study demonstrated that flow cytometry could effectively distinguish tumor cells from lymphocytes in TIL cultures, detecting melanoma cells in all patient enzyme digests. After IL-2-induced TIL expansion, tumor cells were significantly reduced or undetectable.", "population_specificity": "Patients with metastatic melanoma.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:51.822918+00:00"}
{"study_id": 52625, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy and safety of chondroitin sulfate, alone or in combination with glucosamine hydrochloride, in alleviating symptoms and improving dysfunction in patients with Kashin-Beck disease (KBD).", "results_summary": "The combination of chondroitin sulfate and glucosamine hydrochloride significantly reduced WOMAC pain, stiffness, and total scores. Chondroitin sulfate alone also improved WOMAC total and stiffness scores, while glucosamine hydrochloride alone showed no significant effects.", "population_specificity": "251 patients with Kashin-Beck disease (KBD).", "effective_dosage": "Not specified in the abstract.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:52.985670+00:00"}
{"study_id": 52629, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to review clinical studies on disease-modifying interventions, including chondroitin sulfate, for osteoarthritis (OA) progression.", "results_summary": "The abstract mentions chondroitin sulfate as one of the methods being pursued for structural modification interventions in OA, with preliminary findings suggesting potential benefits in modifying OA progression.", "population_specificity": "Adults in the United States with osteoarthritis.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:53.065542+00:00"}
{"study_id": 52627, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of two decellularization protocols on bovine pericardial tissues, assessing mechanical properties and glycosaminoglycan content, including chondroitin/dermatan sulphate.", "results_summary": "BP1 treatment preserved glycosaminoglycans (including chondroitin/dermatan sulphate), while BP2 removed 22% of chondroitin/dermatan sulphate. Mechanical properties were unaffected by BP1 but significantly reduced by BP2.", "population_specificity": "Bovine pericardial tissues (in vitro study).", "effective_dosage": "Not available", "study_duration": "BP1: 12 hours at 4\u00b0C; BP2: 48 hours at 37\u00b0C", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:53.688084+00:00"}
{"study_id": 52628, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of chondroitin sulfate proteoglycans in inhibiting axonal regeneration and how RhoA-inhibition, including by small molecules like ibuprofen, could enhance axonal plasticity and functional recovery after CNS injury.", "results_summary": "The study found that chondroitin sulfate proteoglycans contribute to axonal growth inhibition via the RhoA pathway, and that inhibiting RhoA activation (e.g., with ibuprofen) enhances axonal sprouting, neuroprotection, and motor recovery in spinal cord injury models.", "population_specificity": "Preclinical models of CNS injury, particularly spinal cord injury.", "effective_dosage": "Not specified for chondroitin; ibuprofen dosage not detailed in abstract.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:55.261753+00:00"}
{"study_id": 52631, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the potential of chondroitin sulfate-coated plasmid complexes in gene therapy for ovarian cancer, comparing its antitumor effects to hyaluronic acid.", "results_summary": "Chondroitin sulfate-coated complexes showed higher transfection efficiency and prolonged survival in mice compared to hyaluronic acid, with 100% survival rates in intratumoral injections.", "population_specificity": "Murine ovarian cancer models (C57BL/6 \u00d7 C3H/He F(1) mice).", "effective_dosage": "10-kDa chondroitin sulfate (specific dosage not detailed).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:56.865835+00:00"}
{"study_id": 52632, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to review the effectiveness of slow-acting drugs like chondroitin in preventing cartilage degeneration and compare medical versus surgical treatments for cartilage defects.", "results_summary": "The study found that chondroitin, as part of SADOA, is thought to prevent cartilage degeneration, but no pharmacological therapy has been shown to slow or reverse cartilage destruction. Surgical treatments were more effective for specific cartilage defects but played a lesser role in osteoarthritis.", "population_specificity": "Adults with articular cartilage defects, including those caused by trauma, osteoarthritis, or metabolic disorders.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:59.047697+00:00"}
{"study_id": 52633, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to summarize recent findings on the potential roles of NG2 cells (which express chondroitin sulfate proteoglycan) in various CNS diseases.", "results_summary": "The abstract highlights that NG2 cells play significant roles in traumatic brain injury, multiple sclerosis, glioma, epilepsy, Alzheimer's disease, and electroconvulsive therapy for depression, but does not provide specific results on chondroitin's effects.", "population_specificity": "Not specified (focus on CNS diseases broadly)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:23:59.651267+00:00"}
{"study_id": 52635, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to examine the prevalence and correlates of complementary and alternative medicine (CAM) use, including chondroitin, among individuals with radiographic-confirmed knee osteoarthritis (OA).", "results_summary": "The study found that chondroitin use was associated with severe joint narrowing (OARSI grade 3) and was commonly used alongside conventional medications. However, the abstract does not provide specific efficacy data for chondroitin alone.", "population_specificity": "Individuals with radiographic tibiofemoral knee osteoarthritis (n=2679).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:01.307980+00:00"}
{"study_id": 52634, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to review recent experimental and clinical data on the anti-inflammatory and chondroprotective effects of Chondroitin sulphate (CS) in osteoarthritis.", "results_summary": "The study found that CS demonstrated significant anti-inflammatory effects, inhibiting hind paw oedema, synovitis, and cartilage destruction in animal models. It also showed potential structure-modifying effects and reduced disease markers in adjuvant arthritis, supporting its chondroprotective benefits in humans.", "population_specificity": "Animal models (hind paw oedema, adjuvant arthritis) and human osteoarthritis patients (based on referenced clinical trials).", "effective_dosage": "Dose-dependent effects noted, but specific dosage not provided.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:01.915972+00:00"}
{"study_id": 52636, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of CSPG4 in melanoma tumor progression, its association with cell signaling pathways, and its potential as a target for novel combinatorial therapies.", "results_summary": "The study found that CSPG4 is essential for melanoma tumor growth by modulating integrin function and enhancing growth factor receptor-regulated pathways, including sustained ERK1,2 activation. CSPG4 expression was also linked to chemotherapy resistance in melanoma.", "population_specificity": "Melanoma tumor cells and associated tumor types.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:02.113623+00:00"}
{"study_id": 52637, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to identify the molecular mechanism by which chondroitin sulfate proteoglycans (CSPGs) inhibit axonal growth and explore potential therapeutic interventions to enhance axonal regeneration after CNS injuries.", "results_summary": "The study found that CSPGs inhibit axonal growth via interactions with the neuronal transmembrane leukocyte common antigen-related phosphatase (LAR). Blocking LAR with peptides overcame CSPG-mediated neurite growth restrictions and promoted axon growth and functional recovery in mice with spinal cord injuries.", "population_specificity": "Adult mammals (mice with thoracic spinal cord transection injuries).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:03.917474+00:00"}
{"study_id": 52638, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the efficacy of a dietary supplement containing chondroitin sulfate in combination with glucosamine and quercetin derivatives for managing knee osteoarthritis symptoms.", "results_summary": "The GCQ supplement significantly improved symptom/function subscale scores and aggregate scores compared to placebo, with a trend of improved type II collagen synthesis/degradation balance.", "population_specificity": "40 Japanese subjects with symptomatic knee osteoarthritis.", "effective_dosage": "60 mg chondroitin sulfate per day (combined with 1200 mg glucosamine hydrochloride and 45 mg quercetin glycosides).", "study_duration": "16 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:05.496068+00:00"}
{"study_id": 52623, "supplement_id": 1021, "safety_score": "75", "efficacy_score": 45, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the symptomatic and chondroprotective effectiveness of collagen derivatives, including Chondroitin, in treating osteoarthritis (OA).", "results_summary": "The study found mixed results for Chondroitin's effectiveness, with some pain reduction noted but no significant differences in disability compared to placebo. The overall quality of evidence was moderate to very low, indicating insufficient support for generalized use.", "population_specificity": "Patients with osteoarthritis.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:06.594544+00:00"}
{"study_id": 52639, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the synergistic effects of chondroitinase ABC and motor rehabilitation in promoting spinal cord repair and behavioral recovery.", "results_summary": "The study found that combining chondroitinase ABC with intensive motor rehabilitation had synergistic effects, promoting neural plasticity and behavioral recovery after spinal cord injury. The review discussed both additive and independent effects of these interventions.", "population_specificity": "Spinal cord injury patients (specific population not detailed in abstract).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:06.947001+00:00"}
{"study_id": 52641, "supplement_id": 1021, "safety_score": "85", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the symptomatic effects of highly purified chondroitin 4 and chondroitin 6 sulfate (CS) therapy on pain and function in patients with osteoarthritis (OA) of the hand.", "results_summary": "The study found that CS significantly reduced hand pain and improved hand function compared to placebo, with additional benefits in morning stiffness and investigator-rated treatment efficacy. No significant differences were observed in grip strength, acetaminophen consumption, or safety endpoints between the CS and placebo groups.", "population_specificity": "Symptomatic patients with radiographic evidence of hand OA (n=162), meeting specific pain and functional impairment criteria.", "effective_dosage": "800 mg once daily", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:10.099544+00:00"}
{"study_id": 52642, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effectiveness of hybrid cationized gelatin nanoparticles containing chondroitin sulfate as a gene therapy vehicle to increase MUC5AC production in ocular epithelial cells.", "results_summary": "The study found that the nanoparticles effectively transfected conjunctival cells, leading to increased MUC5AC mRNA and protein expression both in vitro and in vivo, outperforming untreated controls and naked plasmid administration.", "population_specificity": "Ocular epithelial cells (in vitro) and conjunctival tissue (in vivo)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:10.470927+00:00"}
{"study_id": 52640, "supplement_id": 1021, "safety_score": "85", "efficacy_score": 90, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of intravesical instillations of chondroitin sulfate (CS) combined with hyaluronic acid (HA) in regenerating the glycosaminoglycan layer and alleviating symptoms in patients with interstitial cystitis/bladder pain syndrome (IC/BPS).", "results_summary": "The study found significant reductions in urgency, pain scores, and frequency of voids, along with increased urine volume and improved IC Symptom and Problem Index and Pain Urgency Frequency scores. The treatment was well tolerated and effective in this initial experience.", "population_specificity": "22 patients with IC/BPS", "effective_dosage": "40 ml of sodium HA 1.6% and CS 2.0% in 0.9% saline solution, once weekly for 8 weeks, then once every 2 weeks for 6 months", "study_duration": "8 weeks of weekly treatment followed by 6 months of biweekly treatment", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:10.713418+00:00"}
{"study_id": 52643, "supplement_id": 1021, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether a complex of cisplatin and chondroitin sulfate (CDDP-CSA-23) could reduce the toxicity of cisplatin while maintaining its anticancer efficacy.", "results_summary": "CDDP-CSA-23 showed similar anticancer activity to cisplatin but significantly reduced renal toxicity, attenuating declines in urine flow and creatinine clearance, and lowering platinum accumulation in kidney tissues. It also exhibited reduced cytotoxicity on human proximal tubular cells compared to cisplatin alone.", "population_specificity": "Perfused kidneys and human proximal tubular (HK-2) cells (in vitro).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:11.318789+00:00"}
{"study_id": 52644, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the clinical manifestations, diagnosis, and management of MPS IVA, including potential treatments like ERT and HSCT, but did not specifically evaluate Chondroitin's therapeutic effects.", "results_summary": "The abstract does not report specific findings about Chondroitin's effects; it focuses on the disease pathology and potential therapies like ERT and HSCT.", "population_specificity": "Patients with Mucopolysaccharidosis IVA (Morquio A).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:12.697366+00:00"}
{"study_id": 52645, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to compare the responsiveness of different outcome measures, including those related to Chondroitin, in placebo-controlled RCTs for osteoarthritis treatment.", "results_summary": "The study found that Chondroitin, along with other treatments like NSAIDs and glucosamine, showed comparable responsiveness in patient-reported pain outcomes, with treatment effects and standardized effect sizes generally similar to other measures.", "population_specificity": "Patients with osteoarthritis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:13.182472+00:00"}
{"study_id": 52646, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "To determine the effect of chondroitin sulphate on cartilage volume loss, subchondral bone marrow lesions, synovitis, and disease symptoms in patients with knee osteoarthritis.", "results_summary": "Chondroitin significantly reduced cartilage volume loss at 6 months and bone marrow lesions at 12 months compared to placebo, but disease symptoms were similar between groups.", "population_specificity": "Patients with knee osteoarthritis and clinical signs of synovitis.", "effective_dosage": "800 mg once daily", "study_duration": "6 months (double-blind phase) followed by 6 months (open-label phase)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:14.831843+00:00"}
{"study_id": 52647, "supplement_id": 1021, "safety_score": "85", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to assess the feasibility and efficacy of intravesical chondroitin sulfate 0.2% solution in preventing or reducing acute radiation cystitis in women undergoing pelvic radiotherapy.", "results_summary": "The study found that chondroitin sulfate instillations were well tolerated, with minimal bother reported, and may reduce bladder symptom-related bother. Urogenital distress scores remained at or below baseline in treated patients, while controls showed no improvement.", "population_specificity": "Women undergoing pelvic radiotherapy.", "effective_dosage": "40 ml chondroitin sulfate 0.2% solution (intravesical instillation).", "study_duration": "Duration of pelvic radiotherapy (exact length not specified).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:16.150858+00:00"}
{"study_id": 52648, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether digesting chondroitin sulfate proteoglycans could facilitate axon regeneration beyond peripheral nerve grafts in spinal cord injury models.", "results_summary": "The study found that digesting chondroitin sulfate proteoglycans helped regenerating axons exit grafts and form functional synaptic contacts in acute and chronic spinal cord injury models in rats and cats.", "population_specificity": "Rats and cats with acute or chronic spinal cord injuries.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:18.486130+00:00"}
{"study_id": 52650, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to understand the molecular mechanisms and pathways by which chondroitin sulfate proteoglycan binds CXCL4 and induces intracellular signaling.", "results_summary": "The study found that chondroitin sulfate proteoglycan binds CXCL4 and triggers complex intracellular signaling, varying by cell type, involving tyrosine kinases, GTPases, and MAP kinases, with biphasic kinetics leading to redundant or disparate signals.", "population_specificity": "Not specified (cell types analyzed include neutrophils and monocytes).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:19.038962+00:00"}
{"study_id": 52649, "supplement_id": 1021, "safety_score": "75", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential of Chondroitin Sulphate-conjugated PLGA nanoparticles for improving the therapeutic efficacy and safety of the anti-cancer drug 5-FU.", "results_summary": "CS-PEG-PLGA-FU nanoparticles sustained 5-FU release for up to 48 hours, showed the least hemolytic potential, and exhibited enhanced cytotoxicity against MCF-7/MDA-MD 231 breast cancer cells compared to free doxorubicin and other nanoparticle formulations.", "population_specificity": "Breast cancer cells (MCF-7/MDA-MD 231) in vitro.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:19.454245+00:00"}
{"study_id": 52651, "supplement_id": 1021, "safety_score": "30", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate contaminants in heparin, including oversulfated chondroitin sulfate (OSCS), and their potential pathophysiological effects.", "results_summary": "The study found that OSCS and other contaminants activated prekallikrein to kallikrein, triggered complement system activation, formed complexes with platelet factor 4, and induced serotonin release in HIT analysis, indicating potential adverse effects. The contaminants also exhibited variable anticoagulant responses mediated via heparin cofactor II.", "population_specificity": "Not specified (in vitro or ex vivo analysis of contaminants).", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:20.197723+00:00"}
{"study_id": 52653, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review the evidence for the use of chondroitin sulphate as a pharmacological treatment for osteoarthritis, alongside other interventions.", "results_summary": "The abstract mentions chondroitin sulphate as one of the pharmacological treatments discussed, but specific results regarding its efficacy are not detailed. The review highlights the rationale for existing therapies based on clinical studies and trials.", "population_specificity": "Patients diagnosed with osteoarthritis, particularly those not requiring joint replacement surgery.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:20.949712+00:00"}
{"study_id": 52654, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the potential role of chondroitin sulfate in treating osteoarthritis, focusing on symptom management and disease progression.", "results_summary": "The abstract indicates that chondroitin sulfate has been studied for osteoarthritis symptom management and disease modification, but pharmacokinetic and bioavailability data are limited. Clinical trial efficacy and safety data are reviewed but not detailed in the abstract.", "population_specificity": "Osteoarthritis patients (specific demographics not provided).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:22.505497+00:00"}
{"study_id": 52652, "supplement_id": 1021, "safety_score": "90", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to investigate the efficacy and tolerability of intravesical administration of combined hyaluronic acid and chondroitin sulphate in reducing recurrent urinary tract infections (UTIs) in women.", "results_summary": "The study found that HA-CS significantly reduced the UTI rate per patient per year and increased the mean time to UTI recurrence compared to placebo. It also improved urinary symptoms and quality of life without serious adverse events.", "population_specificity": "Female patients with a history of recurrent UTIs.", "effective_dosage": "50 ml of sterile sodium HA 1.6% and CS 2.0% solution weekly for 4 weeks, then monthly for 5 months.", "study_duration": "6 months (initial weekly for 4 weeks, then monthly for 5 months).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:22.658358+00:00"}
{"study_id": 52655, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The study aimed to evaluate the effectiveness of complementary and alternative medicine (excluding glucosamine and chondroitin) in treating osteoarthritis (OA).", "results_summary": "The study did not assess chondroitin, as it was explicitly excluded from the review.", "population_specificity": "Patients with osteoarthritis (specific population details not provided).", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:23.276155+00:00"}
{"study_id": 52656, "supplement_id": 1021, "safety_score": "20", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to review safety concerns related to over-sulfated chondroitin sulfate (OSCS) contamination in low-molecular-weight heparins (LMWHs) and newer anticoagulants.", "results_summary": "The study identified OSCS as a harmful contaminant in LMWHs, linked to fatal anaphylactoid reactions, and raised concerns about product variation, reproducibility, and lack of antidotes for newer anticoagulants.", "population_specificity": "Not specified (global reports of adverse events).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:27.045131+00:00"}
{"study_id": 52657, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the role of chondroitin sulfate proteoglycan 4 (CSPG4) in immunotherapy for melanoma, focusing on its potential to target cancer stem cells and support combinatorial therapies.", "results_summary": "The study highlights CSPG4 as a promising target for melanoma immunotherapy due to its presence on cancer stem cells and pericytes, and its role in tumor growth control. It suggests CSPG4-specific immunity could be effective in managing malignant cell growth.", "population_specificity": "Patients with malignant melanoma and other tumors expressing CSPG4.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:27.323038+00:00"}
{"study_id": 52660, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to review the efficacy and safety of pharmacotherapies, including chondroitin sulfate, for treating hand osteoarthritis in elderly patients.", "results_summary": "The study found that chondroitin sulfate had unclear effects on disease modification in clinical trials, with modest symptomatic efficacy noted.", "population_specificity": "Elderly patients (primaged >60 years) with hand osteoarthritis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:28.409983+00:00"}
{"study_id": 52658, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of chondroitin sulfate C (CSC) on the differentiation of human mesenchymal stem cells (MSCs) into chondrocytes, comparing free CSC, free oligosaccharide CSC, and cross-linked CSC scaffolds.", "results_summary": "The study found that all forms of CSC (free, oligosaccharide, and cross-linked) induced MSC differentiation into chondrocytes, with free oligosaccharide CSC significantly upregulating chondrogenesis gene expression and cartilage ECM accumulation. Cross-linked CSC had the most pronounced effects on MSC chondrogenesis, suggesting potential for cartilage repair in therapy and tissue engineering.", "population_specificity": "Human mesenchymal stem cells (MSCs)", "effective_dosage": "Not specified", "study_duration": "3 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:28.646723+00:00"}
{"study_id": 52659, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to determine the effect of chondroitin, alone or in combination with glucosamine, on joint pain and radiological progression in patients with osteoarthritis of the hip or knee.", "results_summary": "The study found that chondroitin showed a small reduction in pain intensity (-0.3 cm on a 10 cm scale) compared to placebo, but this difference did not meet the prespecified minimal clinically important difference. No significant impact on joint space narrowing was observed.", "population_specificity": "Patients with osteoarthritis of the knee or hip (10 trials, 3803 patients).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:28.907801+00:00"}
{"study_id": 52661, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to analyze the role of chondroitin sulfate in autoimmune diseases, particularly its association with abnormal contact system activation in SLE, RA, and other conditions.", "results_summary": "The study found that chondroitin sulfate is targeted by autoantibodies in SLE and RA, contributing to abnormal contact system activation, but did not assess its therapeutic efficacy or safety.", "population_specificity": "SLE, RA, OA, Ps patients, and healthy controls.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:30.346595+00:00"}
{"study_id": 52663, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 50, "study_goal": "The researchers aimed to review treatment options, including chondroitin, for shoulder osteoarthritis in diabetic patients.", "results_summary": "The abstract mentions chondroitin as a treatment option for shoulder osteoarthritis, but no specific results or efficacy data are provided. It is listed alongside other treatments like NSAIDs and corticosteroid injections.", "population_specificity": "Older age patients with diabetes and shoulder osteoarthritis.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:30.533503+00:00"}
{"study_id": 52662, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of chondroitin sulfate (CS) in the context of adducted thumb-clubfoot syndrome (ATCS), specifically how mutations in CHST14 affect DS biosynthesis and lead to an excess of CS.", "results_summary": "The study found that ATCS mutations cause a decrease or loss of D4ST1 activity, resulting in an absence of dermatan sulfate (DS) and an excess of chondroitin sulfate (CS) in patient fibroblasts, which may alter the physiological pattern of glycosaminoglycans and contribute to clinical symptoms.", "population_specificity": "Patients with autosomal recessive adducted thumb-clubfoot syndrome (ATCS).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:31.891656+00:00"}
{"study_id": 52666, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to review age-related medial degeneration and sclerosis (ARMDS) in elderly populations, noting the accumulation of chondroitin-6-sulfate in aortic media.", "results_summary": "The study found that chondroitin-6-sulfate is a major component of increased aortic mucin in elderly individuals, associated with ARMDS, but did not evaluate its therapeutic effects or safety.", "population_specificity": "Elderly individuals with age-related arterial changes.", "effective_dosage": "Not available", "study_duration": "Not applicable (review study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:36.165140+00:00"}
{"study_id": 52665, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effectiveness of chondroitin sulfate, either alone or in combination with avocado and soybean unsaponifiables (ASU) and glucosamine, in managing osteoarthritis symptoms and potentially slowing its progression.", "results_summary": "The study found that chondroitin sulfate, particularly in combination with ASU and glucosamine, appears beneficial for patients with hip or knee osteoarthritis, with some evidence suggesting prophylactic use in early-stage OA.", "population_specificity": "Patients with hip or knee osteoarthritis.", "effective_dosage": "Not specified for chondroitin sulfate alone; combination included 300 mg of ASU per day.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:36.266096+00:00"}
{"study_id": 52664, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the levels of glycosaminoglycans (GAGs), including chondroitin sulfate, in postmenopausal women with uterine prolapse and assess the effect of 30-day estrogen therapy on these levels.", "results_summary": "The study found that chondroitin sulfate was one of the GAGs detected in the tissues studied, but no significant differences in total GAGs were observed between postmenopausal women with prolapse and the control group. Estrogen therapy increased hyaluronic acid levels but did not significantly alter chondroitin sulfate levels compared to placebo.", "population_specificity": "Postmenopausal women with uterine prolapse and a control group of premenopausal women without prolapse.", "effective_dosage": "0.625 mg oral conjugated estrogens daily for the treatment group.", "study_duration": "30 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:36.848263+00:00"}
{"study_id": 52668, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to review the evidence on whether chondroitinase ABC (ChABC) treatment, alone or combined with other strategies, promotes repair and functional recovery following spinal cord injury.", "results_summary": "The study found that ChABC treatment promotes regeneration of injured axons, plasticity of uninjured pathways, neuroprotection of injured neurons, and significant functional recovery in spinal-injured animals, with results replicated across different injury models and laboratories.", "population_specificity": "Experimental models of spinal cord injury (animal studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:37.445663+00:00"}
{"study_id": 52667, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the role of chondroitin sulfate in platelet-mediated complement activation and its implications in vascular inflammation and thrombosis.", "results_summary": "The study found that chondroitin sulfate is associated with platelet-mediated complement activation, leading to increased inflammatory mediators (C3a and C5a) and potential involvement in autoimmune conditions like APS and ITP. Enhanced platelet-associated complement activation correlated with increased arterial thrombotic events in lupus and APS patients and enhanced platelet clearance in ITP patients.", "population_specificity": "Patients with lupus erythematosus, antiphospholipid syndromes (APS), and immune thrombocytopenia purpura (ITP).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:38.333240+00:00"}
{"study_id": 52669, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to evaluate whether combining chondroitinase ABC (ChABC) with exercise could enhance functional recovery after spinal cord injury by promoting plasticity in the nervous system.", "results_summary": "The study found negative results when combining a single intraparenchymal injection of ChABC with voluntary wheel running exercise in mice with spinal cord injury, highlighting limitations in current protocols for combining these treatments. Further research is needed to optimize timing, type, and quantity of interventions.", "population_specificity": "Mice with mid-thoracic spinal contusion injury.", "effective_dosage": "Single intraparenchymal injection of ChABC.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:39.412207+00:00"}
{"study_id": 52670, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 40, "quality_score": 65, "study_goal": "The researchers aimed to characterize the structural changes in glycosaminoglycans (GAGs), including chondroitin sulfate, in urine and plasma of MPS I patients before and during enzyme-replacement therapy (ERT).", "results_summary": "The study found that ERT did not completely eliminate chondroitin sulfate-rich GAGs from urine, indicating limited efficacy at standard doses. A variable effect of ERT was observed across administrations.", "population_specificity": "Two patients with the Hurler-Scheie form of MPS I undergoing ERT for 6 years.", "effective_dosage": "Not specified", "study_duration": "Two-week period of enzyme infusion (long-term ERT duration: 6 years)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:40.349408+00:00"}
{"study_id": 52671, "supplement_id": 1021, "safety_score": "85", "efficacy_score": 30, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the efficacy and safety of chondroitin sulphate (CS), alone or in combination with glucosamine, compared to celecoxib and placebo for treating painful knee osteoarthritis over 2 years.", "results_summary": "The study found that CS alone did not achieve a statistically significant reduction in WOMAC pain compared to placebo, with an odds ratio of 0.69. Adverse reactions were similar across all treatment groups, and serious adverse events were rare.", "population_specificity": "662 patients with knee osteoarthritis (Kellgren/Lawrence grade 2 or 3 changes and baseline joint space width \u22652 mm).", "effective_dosage": "400 mg three times daily.", "study_duration": "24 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:41.305400+00:00"}
{"study_id": 52675, "supplement_id": 1021, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to assess the efficacy and safety of chondroitin sulphate (CS) in relieving symptoms of knee osteoarthritis (OA) and psoriasis in patients with both conditions.", "results_summary": "CS was more effective than placebo in reducing knee OA pain, decreasing the Lequesne index, and reducing acetaminophen use. It also improved plantar psoriasis and quality of life but showed no significant effects on other psoriasis measures.", "population_specificity": "129 patients with symptomatic knee OA and concomitant psoriasis.", "effective_dosage": "800 mg daily.", "study_duration": "3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:45.838577+00:00"}
{"study_id": 52672, "supplement_id": 1021, "safety_score": "75", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to compare the efficacy and safety of intravesical chondroitin sulfate versus an inactive vehicle control for treating interstitial cystitis/painful bladder syndrome (IC/PBS).", "results_summary": "The study found that 39.4% of patients in the chondroitin group reported clinically significant improvement compared to 22.6% in the control group, though the difference was not statistically significant. Adverse events were common but mostly mild or moderate, with fewer intervention-related events in the chondroitin group.", "population_specificity": "Patients with interstitial cystitis/painful bladder syndrome (IC/PBS).", "effective_dosage": "2.0% sodium chondroitin sulfate administered intravesically weekly.", "study_duration": "6-week treatment period followed by a 6-week follow-up.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:45.961713+00:00"}
{"study_id": 52673, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to explore the role of midkine in binding to chondroitin sulfate and its implications in cellular activities, tissue repair, and disease processes.", "results_summary": "The study found that midkine binds to chondroitin sulfate and is involved in cell migration, survival, tissue repair, inflammation, and tumor growth. Midkine inhibitors may be effective for treating various conditions, including malignancies and inflammatory diseases.", "population_specificity": "Not specified (general biological mechanisms discussed).", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:46.049497+00:00"}
{"study_id": 52674, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the immune-modulator effect of chondroitin sulfate (CS) by reviewing existing literature, focusing on its potential benefits in diseases with inflammatory components.", "results_summary": "CS reduces NF-kappaB activation and nuclear translocation, potentially explaining its benefits in osteoarthritis and suggesting utility in other inflammatory diseases like psoriasis, inflammatory bowel diseases, and neurodegenerative disorders. Preliminary evidence supports its efficacy, but further clinical trials are needed.", "population_specificity": "Not specified (literature review covering various experimental and clinical studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:46.785700+00:00"}
{"study_id": 52677, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to summarize the mechanisms of action of chondroitin sulfate in the pathophysiology of osteoarthritis joint tissues.", "results_summary": "Chondroitin sulfate stimulates proteoglycan synthesis, reduces catabolic activity in chondrocytes, exerts anti-inflammatory effects, and modulates bone resorption in osteoarthritic subchondral bone. Effects vary based on origin and purity of chondroitin sulfate.", "population_specificity": "Patients with osteoarthritis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:47.055750+00:00"}
{"study_id": 52678, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to investigate whether chondroitin sulphate (CS) could control atherosclerotic lesions in a rabbit model of atherosclerosis aggravated by chronic arthritis.", "results_summary": "The preliminary study suggested a beneficial effect of chondroitin sulphate in controlling atherosclerotic lesions, though clinical trials in humans are needed to confirm these findings.", "population_specificity": "Rabbit experimental model of atherosclerosis aggravated by chronic arthritis.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:47.808172+00:00"}
{"study_id": 52676, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the neuroprotective, antioxidant, and anti-inflammatory effects of chondroitin sulfate (CS) in the central nervous system (CNS).", "results_summary": "The study found that CS exhibits neuroprotective effects by activating PKC/PI3K/Akt signaling, inducing antioxidant enzymes, and suppressing caspase-3 activation. Additionally, a disaccharide derived from CS degradation (CSGP-DS) showed protective effects against neuronal toxicity in vitro and in vivo, reducing TNF-alpha secretion and blocking NF-kappaB translocation.", "population_specificity": "Human neuroblastoma SH-SY5Y cells and cortical neurons; in vivo models of experimental autoimmune encephalomyelitis and uveitis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:48.587600+00:00"}
{"study_id": 52679, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to assess the efficacy of chondroitin sulfate as a structure-modifying drug for knee osteoarthritis by updating a meta-analysis of randomized controlled trials.", "results_summary": "The pooled results showed a small but significant effect of chondroitin sulfate in reducing the rate of decline in minimum joint space width (0.13 mm, P=0.0002), with an effect size of 0.23 (P=0.0001), indicating efficacy for knee osteoarthritis.", "population_specificity": "Patients with knee osteoarthritis", "effective_dosage": "Not specified", "study_duration": "2 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:49.847480+00:00"}
{"study_id": 52680, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The abstract does not focus on evaluating Chondroitin's effects but rather describes Mucopolysaccharidosis VI (MPS VI) and its associated enzyme deficiency.", "results_summary": "The abstract does not report any findings related to Chondroitin's effects, as it primarily discusses MPS VI pathology, diagnosis, and treatment with galsulfase.", "population_specificity": "Patients with Mucopolysaccharidosis VI (MPS VI).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:53.541009+00:00"}
{"study_id": 52682, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 40, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy and stability of evidence for chondroitin sulfate in pain relief for osteoarthritis, comparing new data (2006-2009) to prior findings.", "results_summary": "The study found that the effect size for pain relief from chondroitin sulfate diminished, with greater heterogeneity of outcomes and more evidence of publication bias.", "population_specificity": "Patients with hip and knee osteoarthritis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:53.816731+00:00"}
{"study_id": 52684, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate whether chondroitin sulfate and glucosamine could slow joint-space narrowing in adult patients with Kaschin-Beck disease (KBD).", "results_summary": "The study found that the chondroitin sulfate and glucosamine group showed no significant joint-space narrowing compared to the placebo group, suggesting a protective effect on articular cartilage in KBD patients. The overall mean change in joint space was significantly different between the two groups.", "population_specificity": "Adult patients (aged over 40 years) with Kaschin-Beck disease (KBD).", "effective_dosage": "1,600 mg oral mixture of chondroitin sulfate and glucosamine twice daily.", "study_duration": "8 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:56.288547+00:00"}
{"study_id": 52685, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to identify genetic polymorphisms associated with response and toxicity in prostate cancer patients treated with docetaxel and thalidomide, including the role of CHST3 (chondroitin 6 sulfotransferase 3).", "results_summary": "The study found that genetic variations in CHST3 were potentially associated with both response to therapy and toxicities in prostate cancer patients treated with docetaxel and thalidomide.", "population_specificity": "Patients with prostate cancer enrolled in a randomized phase II trial.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:56.420024+00:00"}
{"study_id": 52683, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the efficacy of sodium hyaluronate (Na-HA) and corticosteroid (CS) injections in treating knee osteoarthritis, focusing on clinical scores and biochemical markers including chondroitin sulfates.", "results_summary": "Both Na-HA and CS injections improved pain and inflammation scores, with Na-HA showing additional benefits like increased hyaluronan levels and reduced MMP-9 levels, suggesting potential cartilage protection. Chondroitin sulfate levels were measured but did not show significant changes between groups.", "population_specificity": "51 patients with knee osteoarthritis.", "effective_dosage": "Not specified for chondroitin sulfates (measured as biomarkers, not administered).", "study_duration": "6 months follow-up after treatment.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:56.699467+00:00"}
{"study_id": 52687, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess the structural efficacy of daily chondroitin sulfate in delaying joint space narrowing in patients with knee osteoarthritis.", "results_summary": "Chondroitin sulfate showed a small but significant protective effect on minimum joint space narrowing after 2 years of treatment, suggesting it may delay radiological progression of knee osteoarthritis.", "population_specificity": "Patients with knee osteoarthritis", "effective_dosage": "Not specified", "study_duration": "2 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:56.847569+00:00"}
{"study_id": 52686, "supplement_id": 1021, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 80, "study_goal": "The researchers aimed to assess the effect of intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP) on malaria-specific immunity in pregnant women, including antibody responses related to chondroitin sulfate A-binding parasites.", "results_summary": "HIV-positive mothers receiving SP had lower levels of certain antibodies compared to placebo recipients, but this reduction did not increase malaria-associated morbidity. No differences were observed in HIV-negative mothers.", "population_specificity": "Pregnant women (177 HIV-negative, 88 HIV-positive, 37 unknown HIV status) in sub-Saharan Africa.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:57.131681+00:00"}
{"study_id": 52681, "supplement_id": 1021, "safety_score": "90", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to compare the efficacy and safety of avocado soybean unsaponifiable (ASU) once daily versus chondroitin sulfate three times daily in treating femorotibial gonarthrosis over a 6-month period, including a 2-month post-treatment observation.", "results_summary": "The study found no statistically significant difference in efficacy or safety between ASU and chondroitin sulfate, with both treatments reducing the WOMAC-index by approximately 50% and showing continued slight improvement post-treatment. Over 80% of patients rated the overall efficacy as excellent or good in both groups, and both treatments were well-tolerated.", "population_specificity": "Patients with femorotibial gonarthrosis (n=361 evaluable).", "effective_dosage": "Chondroitin sulfate 400 mg three times daily.", "study_duration": "6 months of treatment, followed by 2 months of post-treatment observation.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:24:57.181540+00:00"}
